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Summary 
Sustainability of energy generation and careful use of environmental resources are two of our 
biggest challenges in the world today. Ecological and energy crises in every country enforce the 
need for development and exploration of sustainable bioenergy resources. One novel 
biotechnological approach to implement the means of converting and conserving resources are 
bioelectrochemical systems or BES. The main advantage of BES application is the generation of 
electric power or biochemical products from renewable materials and carbon-neutral waste 
materials. The recent exploration and study of natural microbial electron discharge to 
extracellular anodes might offer significant improvements strategies in bioelectrochemical 
processes for the production of many valuable products, such as bio detergents. However, the 
natural activity of biocatalysts on electrodes is limited, and molecular engineering approaches 
are required to tailor new bioelectrochemical active production hosts. Schmitz et al has just 
reported a successful initial proof-of-principle study. propose a new concept of using an 
engineered strain of Pseudomonas putida to enable the utilization of an anode for electron 
discharge during oxygen-limited growth (Schmitz et al., 2015). Biotechnologically, this organism 
is already tailored to produce bio-detergents like rhamnolipids, one type of glycolipid 
surfactants, under aerobic conditions. But costly aeration and subsequent problems with 
vigorous reactor foaming, which is technically hard to handle with conventional antifoam 
technologies, are current drawbacks. This challenge might be overcome if the detergent 
production is combined with oxygen-limited growth in bioelectrochemical systems. 
In this study, following the work from Schmitz et al., we successfully expressed the other three 
phenazine synthesis gene originating from the phenazine synthesis operon two of P. aeruginosa 
PAO1 (PA1899-PA1905), operon one of P. aeruginosa PA14 (PA14_09410-PA14_09480), and 
operon two of P. aeruginosa PA14 (PA14_39880-PA14_39970). Notably, the phenazine-1-
carboxylic acid (PCA) synthesis operon two from P. aeruginosa PA14 was found to be most 
active in the heterologous phenazine production within P. putida. This gene origin was chosen 
to be tailored further with rhamnolipid production. Hereinafter, the heterologous mono-
rhamnolipid production in P. putida has been successfully coupled with phenazine production to 
generate the strains P. putida rhl-pca (produces PCA and mono-rhamnolipids) and P. putida rhl-
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pyo (produces PCA, pyocyanin (PYO), and mono-rhamnolipids). Based on the maximum titer of 
mono-rhamnolipids produced in aerobic shake flasks, P. putida rhl-pca was chosen for 
bioelectrochemical production experiments in BES.  
Oxygen-limited cultivations with redox balancing at an anode via phenazines can be coupled to 
rhamnolipid biosynthesis by employing plasmid-based genetic engineered P. putida. The result 
of our study showed that passive headspace aeration of BES was suitable to be applied for the 
bioelectrochemical production of foam-free rhamnolipids with P. putida rhl-pca. The increased 
carbon yield obtained by P. putida rhl-pca in passively aerated BES showed a potential economic 
advantage for glycolipid surfactant bioproduction. Overall, this work is an initial study showing 
that the bioelectrochemical production of foam-free glycolipid surfactants by utilizing 
phenazines as electron shuttles is possible.  
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Zusammenfassung 
Nachhaltigkeit bei der Energieerzeugung und bei der Nutzung von Umweltressourcen sind 
heutzutage zwei unserer größten Herausforderungen auf der Welt. Umwelt- und Energiekrisen 
in allen Ländern erfordern die Entwicklung und Erforschung nachhaltiger Bioenergieressourcen. 
Ein neuartiger biotechnologischer Ansatz zur Umwandlung und Schonung von natürlichen 
Ressourcen sind bioelektrochemische Systeme oder BES. Hauptvorteil der BES ist die Erzeugung 
von elektrischem Strom oder biochemischen Produkten aus nachwachsenden Rohstoffen und 
klimaneutralen Abfällen. Die jüngste Erforschung der natürlichen mikrobiellen 
Elektronübertragung auf extrazelluläre Anoden könnte signifikante Verbesserungen in der 
Anwendung bioelektrochemischen Prozessen zur Herstellung vieler wertvoller Produkte wie 
Biodetergenzien nach sich ziehen. Die natürliche Aktivität von Biokatalysatoren an Elektroden 
ist jedoch begrenzt, und molekulartechnische Ansätze sind erforderlich, um neue 
bioelektrochemisch aktive Produktionswirte maßzuschneidern. Eine erfolgreiche erste Proof-of-
Principle-Studie wurde kürzlich von Schmitz et al. veröffentlicht. Hierbei wurde ein genetisch 
veränderter Stamm von Pseudomonas putida genutzt, welcher eine BES Anode zur 
Elekronenentladung während sauerstoffbegrenzten Wachstums nutzen kann (Schmitz et al., 
2015). Biotechnologisch wird P. putida bereits genutzt um unter aeroben Bedingungen 
Biowaschmittel wie Rhamnolipide, eine Art von Glykolipid-Tensiden, herzustellen. Aber teure 
Belüftung und anschließende Probleme mit starker, technisch nur schwer zu kontrollierender 
Schaumbildung, limitieren den Prozess. Diese Herausforderung könnte überwunden werden, 
wenn die Waschmittelproduktion mit einem sauerstoffbegrenzten Wachstum in 
bioelektrochemischen Systemen einhergeht. 
In der hier vorliegenden Disserationsarbeit wurde die Arbeit von Schmitz et al. fortgesetzt und 
die anderen drei Phenazinsynthese-Operone erfolgreich exprimiert: Hierbei handelt es sich um 
das Phenazinsyntheseoperon 2 aus P. aeruginosa PAO1 (PA1899-PA1905), das Operon 1 aus 
P. aeruginosa PA14 (PA14_09410-PA14_09480) und das Operon 2 aus P aeruginosa PA14 
(PA14_39880-PA14_39970). Bemerkenswerterweise erwies sich das Phenazin-1-carbonsäure 
(PCA) Syntheseoperon 2 aus P. aeruginosa PA14 als am aktivsten bei der heterologen 
Phenazinproduktion in P. putida. Dieses Operon wurde daher ausgewählt, um mit der 
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Rhamnolipid-Produktion integriert zu werden. Hierbei konnte die heterologe Mono-
rhamnolipid-Produktion in P. putida erfolgreich mit der Phenazinproduktion gekoppelt werden. 
Dabei wurden die Stämme P. putida rhl-pca (produziert PCA und Mono-rhamnolipide) und 
P. putida rhl-pyo (produziert PCA, Pyocyanin (PYO) und Mono-rhamnolipide) generiert. 
Basierend auf dem maximalen Titer an Mono-rhamnolipiden, welche in aeroben Schüttelkolben 
produziert wurden, wurde P. putida rhl-pca für bioelektrochemische Produktionsexperimente in 
BES ausgewählt. 
Ich konnte zeigen, dass sauerstoffbegrenzte Kultivierungen von gentechnisch veränderten 
P. putida unter Redoxausgleich an einer Anode mit Hilfe von Phenazinen möglich sind. Hierbei 
kann der Stamm so verändert werden, dass gleichzeitig eine Rhamnolipid-Biosynthese 
stattfinden kann. Das Ergebnis unserer Studie zeigt, dass die passive Luftraumbegasung in BES 
für die bioelektrochemische Herstellung von schaumfreien Rhamnolipiden mit P. putida rhl-pca 
geeignet ist. Die erhöhte Kohlenstoffausbeute mit P. putida rhl-pca in passiv belüfteten BES ist 
ein potentieller wirtschaftlicher Vorteil bei der Glykolipid-Tensid Bioproduktion. Insgesamt ist 
diese Arbeit eine erste Studie, die zeigt, dass die bioelektrochemische Herstellung von 
schaumfreien Glykolipid-Tensiden unter Verwendung von Phenazinen als Elektronen-Shuttle 
möglich ist. 
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1.1 Valuable microbial glycolipids as sustainable surfactant compound 
Glycolipids are a group of compounds, which consist of a mono- or oligosaccharide bound to a 
lipid molecule by a glycosidic linkage (Lopez & Schnaar, 2006). Based on their hydrophobic 
moieties, glycolipids can be divided into glycoglycerolipids and glycosphingolipids. Due to the 
presence of both hydrophobic and hydrophilic moieties, the amphiphilic glycolipids show 
surface activity. They can, therefore, be used as an eco-friendly alternative to commonly used 
surfactants, which classically are non-biodegradable and contain highly toxic compounds, such 
as ethylene oxide (Faivre & Rosilio, 2010). Siebenhaller et al. described that the majority of 
surfactants used today, are produced from petroleum-based material and contain aryl or alkyl 
units as the hydrophobic moiety, as well as sulfonates, alkylammonium salts, amines and 
carboxylates as the hydrophilic moiety (Siebenhaller et al., 2018). However, in more recent 
times, surfactants are starting to be produced from renewable resources, and are therefore 
called “biosurfactants” (Lourith & Kanlayavattanakul, 2009; Santos et al., 2016; Siebenhaller et 
al., 2018). Glycolipid surfactants are one specific group of these “biosurfactants” (Figure 1). They 
can contain anionic- and/or cationic charged groups. Hence, they can be grouped into nonionic, 
anionic, cationic, and amphoteric surfactants. These group of compounds is very useful as an 
additive agent in food processing, cosmetic, agrochemical, cleaning agents/detergents, and 
pharmaceutical applications, like the production of foam, emulsions, and dispersions 
(Sivapathasekaran & Ramkrishna, 2017). 
One group of glycolipid surfactants is microbial glycolipids, which are non-toxic to the 
environment and biodegradable. Microbial glycolipids can be produced under aerobic or 
anaerobic conditions, depending on the specific compound (Reis et al., 2011). Several examples 
of microbial glycolipids are shown in Figure 1. Mannosylerythritol lipids (Figure 1a) are naturally 
produced by Pseudozyma sp. and are industrially attractive glycolipids due to their manifold 
potential applications in pharmaceuticals, bioremediation of petroleum hydrocarbons, and as a 
chemical agent in protein purification (Rau et al., 2005). Another group of glycolipid surfactants 
is sophorolipids (Figure 1c), which are mainly produced by Candida bombicola in nature 
(Kulakovskaya & Kulakovskaya, 2014). This group of glycolipid surfactant is regarded as a 
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promising candidate of biomedical compounds, as they are an effective and safe antimicrobial 
agent (Diaz De Rienzo et al., 2015). Therefore, this type of glycolipids presents a promising 
alternative to synthetic medicines (Joshi-Navare & Prabhune, 2013). Furthermore, a short 
review of rhamnolipids (Figure 1b) is given in section 1.2 of this chapter. 
 
 
Figure 1: Examples of valuable glycolipid surfactants (a) mannosylerythritol lipids (Siebenhaller et al., 2018), (b) 
rhamnolipids (Chong & Li, 2017), and (c) sophorolipids (Kulakovskaya & Kulakovskaya, 2014)  
 
1.2 Rhamnolipids as a valuable glycolipid surfactant 
Rhamnolipids are one of the best explored microbial glycolipid surfactants. This group of 
compounds provides a wide range of industrial applications, for example in the food, 
pharmaceutical, cosmetics industry, in pollutant bioremediation, and as a cleaning agent 
(detergents) (Chong & Li, 2017; Soberon-Chavez et al., 2005). Rhamnolipids are naturally 
produced by Pseudomonas and Burkholderia (Caiazza et al., 2005; Rikalovic et al., 2017), 
whereby its production is controlled by the complex regulation of quorum sensing (Dusane et 
al., 2010). The tension-active properties of these compounds enable those bacteria to reduce 
the surface tension of hydrophobic substrates and generate emulsions, which increase the 
medium solubility. The ability of these bacteria to produce rhamnolipids broadens the range of 
carbon sources they can utilize as substrate (Nickzad et al., 2015; Wilhelm et al., 2007). The 
genes rhlA and rhlB are needed for the synthesis of mono-rhamnolipids. Those mono-
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rhamnolipids can be combined by RhlC and are then termed di-rhamnolipids (Figure 2). The rhlA 
gene encodes the acyltransferase/HAA synthase (RhlA), which is responsible for the synthesis of 
the fatty acid dimers 3-(3-hydroxy-alkanoyl-oxy) alkanoic acids (HAAs). They are formed via the 
esterification of two 3-hydroxy-fatty acids that are either linked to the acyl carrier protein 
(derived from de novo synthesis of fatty acids) or alternatively linked to the coenzyme A 
(derived from β-oxidation of fatty acid). The rhlB gene encodes the rhamnosyltransferase I 
(RhlB), which catalyzes the reaction of combing the HAA molecule with a dTDP-L-rhamnose 
(derived from glucose-6-phosphate) to produce mono-rhamnolipids. Furthermore, the rhlC gene 
encodes rhamnosyltransferase II (RhlC), which couples a second dTDP-L-rhamnose molecule to 
the mono-rhamnolipid to produce a di-rhamnolipid (Abdel-Mawgoud et al., 2014; Bahia et al., 
2018; Wittgens et al., 2017). The microbial rhamnolipids are a mixture of different rhamnose 
residues and varying chain length of the β-hydroxy-fatty acid (indicated by the number after 
carbon atom). For example, the mono-rhamnolipid congeners produced by Pseudomonas 
aeruginosa consist of four compounds, which are Rha-C10-C10 (foremost), Rha-C8-C10, Rha-C10-
C12, and Rha-C10-C12:1, containing an unsaturated carbon chain (Rendell et al., 1990; Tiso et al., 
2017). On the other hand, the rhamnolipids produced by Burkholderia contain long-chain fatty 
acid, predominantly with C14-C14 (Wittgens et al., 2018). 
The heterologous production of rhamnolipids using a recombinant host to avoid the 
employment of pathogenic bacteria has been well developed (Tiso et al., 2016; Tiso et al., 2017; 
Wittgens et al., 2018; Wittgens et al., 2011). One such host is, for example, Pseudomonas putida 
KT2440. However, scale-up production using common bioreactors requires strong aeration. This 
causes strong reactor foaming and reduces the yield, which is challenging to be overcome with 
conventional antifoam technologies (Beuker et al., 2016; Küpper et al., 2013). Hence, an 
alternative approach to facilitate the production of rhamnolipids by applying micro-aeration 
(oxygen-limited) reactor systems will be interesting and useful for foam-free rhamnolipids 
generation. 
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Figure 2: Rhamnolipid biosynthesis by Pseudomonas, adopted from Chong and Li (Chong & Li, 2017) 
 
1.3 Pseudomonas putida KT2440 as multifaceted biocatalyst 
Based on its GRAS (Generally Recognized As Safe) qualification, P. putida KT2440 is a non-
pathogenic Pseudomonas species, which has emanated as a versatile recombinant host (Nikel & 
de Lorenzo, 2018). This bacteria stands out as a multifaceted biocatalyst due to the availability 
of extensive genetic and intrinsic metabolism information, combined with its tolerance to many 
chemical and biochemical substances (Loeschcke & Thies, 2015; Martinez-Garcia et al., 2014) 
This allows the strain to grow in the presence of various toxic chemicals and solvents (Calero & 
Nikel, 2019). Moreover, biocatalysis with this strain in organic systems allows for direct product 
removal of hydrophobic compounds, hence simplifying the purification process (Blank et al., 
2008; Lang et al., 2014; Nikel et al., 2014).  
Physiologically, P. putida KT2440 is a gram-negative saprophytic soil bacterium, which colonizes 
the rhizosphere (Fernandez et al., 2013). This bacterium is an obligately aerobic, as it employs 
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oxygen as the terminal electron acceptor. During its metabolism, it generates a high net 
NAD(P)H amount for enzymatic catabolism reactions, without the metabolic capacity for 
fermentation, anaerobic redox balancing or electron discharge (Escapa et al., 2012; Lai et al., 
2016). The catabolism reaction of various substrates in P. putida KT2440 has been well studied. 
For example, the glucose metabolism is catalyzed by various enzymes, which are involved in 
several pathways, i.e. the Entner-Doudoroff pathway and the pentose phosphate pathway 
(Nikel et al., 2015; Sudarsan et al., 2014). The strain is able to accumulate biodegradable 
thermoplastic polymers, the poly-hydroxy-alkanoates (PHAs) as a carbon and energy storage 
material under growth-limited condition (Escapa et al., 2012). 
Furthermore, the complete genome sequences and metabolomics studies of P. putida KT2440 
are well established (Ballerstedt et al., 2007; Belda et al., 2016), opening the possibility for 
further genetic modifications. Hence, extends its usage for the heterologous production of 
valuable compounds. In comparison to P. aeruginosa PAO1, P. putida shares 85% similarity in 
the DNA sequence (Nelson et al., 2002). Therefore, P. putida KT2440 is a potential biocatalyst to 
be employed in the heterologous expression of various genes originating from P. aeruginosa. 
 
1.4 Bioelectrochemical systems as a means of converting and conserving 
resources 
The necessity of sustainable energy and environmental awareness propels the exploration and 
development of sustainable bioenergy resources. One of the biotechnological approaches to 
implement novel means of converting and conserving resources is the use of bioelectrochemical 
systems or BES. BES can thereby be utilized to generate bioelectricity from renewable (often 
waste) carbon sources or to sustainably produce platform chemicals through the interaction of 
microorganisms with a polarized electrode (Bajracharya et al., 2016). Therefore, BES is also a 
device that can be applied in the bioprocess of platform chemicals production. 
As a bioprocessing system, BES involve microbial whole-cell biocatalysts to drive oxidation and 
reduction (redox) reactions at solid electrodes (Rosenbaum & Henrich, 2014). One example of a 
BES technology is the microbial fuel cell (MFC) (Figure 3b). In this system, the microorganism 
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catabolizes the organic matter and the electron produced from this catabolism reaction will be 
accepted by the BES anode. To generate the electricity, this electron moves through an external 
circuit to a cathode, where it combines with oxygen and protons to form water (Watanabe et 
al., 2009). In order to simplify the BES study in the laboratory, we are using a potentiostatically 
controlled BES (Figure a). In general, a potentiostatically controlled BES consists of the working 
electrode (anode), at which the microbial oxidation processes take place, a counter electrode 
(cathode), and a reference electrode, which has a stable and well-known electrode potential 
(Pant et al., 2012).  
 
 
Figure 3: The general set up of a potentiostatically controlled BES and MFC. (a) is a schematic representation of a 
single-chambered BES, consisting of an anode as working electrode (WE), cathode as counter electrode 
(CE), and a reference electrode, which has a stable and well-known electrode potential (RE) and (b) a 
scheme of a two-chambered MFC separated by a proton exchange membrane (R: resistor). The schemes 
are modified from Logan et al. (Logan et al., 2006) 
 
In relation to the presence of surfactants, it has been known that the addition of surfactant is 
efficiently increasing the current generation of MFC (Wen et al., 2010). Examples of synthetic 
surfactants have been tested to improve the MFC performance, particularly gaining the 
bacterial extracellular electron transfer, such as EDTA, polyethyleneimine, and Tween-80 (Liu et 
al., 2012; Wen et al., 2011). However, the addition of synthetic surfactant in the MFC can be 
toxic for the bacteria (Shen et al., 2014). Therefore, the study to understand the optimum 
concentration and condition of synthetic surfactant addition in the MFC is required. 
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Additionally, the surfactant produces by the bacteria so-called as biosurfactant, emerges less 
characteristic of toxicity to the bacteria, such as rhamnolipids and sophorolipids. However, the 
addition of exogenous biosurfactant resulted in the high cost of MFC operation. Ideally, the 
biosurfactant is endogenously produced by the bacterial MFC. It will be advantages 
physiologically and economically for MFC performance. However, the biosurfactant synthesis by 
the natural biosurfactant producer bacteria is tightly controlled by the complex genetic 
regulatory network (quorum sensing). Therefore the production of surfactant using the 
recombinant host bacteria disconnecting the quorum sensing system will be more beneficial. 
The extracellular electron transfer mechanism between microorganisms and electrodes can be 
differentiated in direct electron transfer (DET) and indirect (mediated) electron transfer. DET 
involves physical contact of the bacterial redox-active membrane with the anode of the BES, e.g. 
through nanowires and c-type cytochromes. On the other hand, MET involves a redox shuttling 
compound as the primary electron transfer pathway (Figure 4), which can either be exogenous 
(artificially added in the system) or endogenous (naturally synthesized by the microorganism) 
(Harnisch et al., 2011). Endogenous mediators, e.g., phenazines, have multiple advantages over 
exogenous mediators like methylene blue (Rahimnejad et al., 2011), neutral red (Popov et al., 
2012) or ferricyanide (Hu et al., 2015). They do not require costly addition of chemical 
compounds and are likely produced throughout the process, while the production is linked to 
the activity of the producing microorganism. A disadvantage is that only certain microbial 
species are naturally equipped to produce endogenous redox mediators for extracellular 
electron transfer. 
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Figure 4: A scheme of extracellular electron transfer via redox shuttling compound, e.g., phenazines (Phz). The 
red dot indicated the membrane-bound compound involves in the mediated electron transfer. The scheme 
is modified from Harnisch et al. (Harnisch et al., 2011) 
 
1.5 Phenazines as electron shuttle compound in BES 
One group of redox compounds studied for natural MET are microbial phenazines, which are 
produced by Pseudomonas species, especially by Pseudomonas aeruginosa (Figure 5) (Averesch 
& Kromer, 2018; Logan et al., 2006). There are two types of phenazines; phenazine-1-carboxylic 
acid (PCA) and pyocyanin (PYO), which are predominantly produced by P. aeruginosa in oxygen-
limited BES (Berger & Rosenbaum, 2017; Bosire et al., 2016). In the environment, phenazines act 
as a virulence factor of P. aeruginosa by reducing the molecular oxygen into reactive oxygen 
species, which are toxic for other microbial species (Das et al., 2015; Mentel et al., 2009). On the 
other hand, the study of BES co-culture between P. aeruginosa and Enterobacter aerogenes, 
phenazines can promote synergistic interaction between species and be utilized further for 
electron discharge (Schmitz & Rosenbaum, 2018; Venkataraman et al., 2011). The property and 
redox activity of the phenazines have been well studied, for example, PYO tends to be reactive 
with oxygen (at neutral pH)(Dietrich et al., 2006), while PCA is more reactive to solid electron 
acceptors (Wang & Newman, 2008). Furthermore, a recent study revealed that the positive 
potential applied in the oxygen-limited BES of P. aeruginosa increased PCA production (Bosire & 
Rosenbaum, 2017). In the case of anaerobic cultivation, it has been revealed by Glasser et al. 
10 
 
that phenazine redox cycling enables P. aeruginosa to promote survival by coupling acetate and 
ATP synthesis (Glasser et al., 2014). The oxidation of glucose and pyruvate into acetate by 
acetate kinase activity found to be correlated with the ATP synthesis in the anaerobic survival 
mechanism (Eschbach et al., 2004). It shows that phenazines can facilitate energy generation, 
which might broaden the metabolic versatility of microorganisms. 
The complex regulatory network of phenazine synthesis and the pathogenic nature of 
P. aeruginosa limit the application of phenazine redox mediation for specific biotechnological 
applications with this host (Dietrich et al., 2006). A successful initial proof-of-principle study has 
been reported by our lab in 2015 (Schmitz et al., 2015), introducing an engineered strain of non-
pathogenic, aerobic P. putida KT2440, in which heterologous phenazine synthesis enables 
electron discharge to an extracellular anode under oxygen-limited conditions in BES. The 
heterologous expression of the nine phenazine synthesis genes from P. aeruginosa PAO1 
(phzA1-G1, phzM, and phzS) in P. putida KT2440, resulted in the production of PCA and PYO. The 
derivative PYO was only fully synthesized when active aeration was applied during the initial 
growth phase since the final enzyme PhzS is dependent on molecular oxygen. During 
subsequent passive aeration via opened vent filter (i.e., strong oxygen limitation of the culture), 
metabolic activity sustained, and PCA was further synthesized and accumulated. Thereby, the 
total produced phenazine concentrations in BES were in the upper range of phenazine 
concentrations produced by the native producer P. aeruginosa (30–40 μg/mL for P. putida pPhz 
(Schmitz et al., 2015) vs. 22–25 μg/mL for P. aeruginosa PA14) (Bosire et al., 2016).  
 
 
Figure 5: Phenazine biosynthesis pathways in P. aeruginosa. The scheme is modified from Parsons et al. (Parsons 
et al., 2007) 
 
To develop an efficient P. putida biocatalyst for oxygen-limited bioelectrochemical production, 
it is necessary to explore further and optimize its heterologous production of phenazines. The 
work conducted by Bosire et al. showed for several carbon sources that P. aeruginosa PA14 
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produces more phenazines and results in higher anodic currents than P. aeruginosa PAO1 within 
an oxygen-limited BES setup (Bosire et al., 2016). This strain dependency of phenazine synthesis 
may be already encoded in the genetic origin for the phenazine synthesis genes in these strains. 
The original producer of phenazines, P. aeruginosa, encodes for two homologous operons; 
phzA1-G1 (operon 1/phz1) and phzA2-G2 (operon 2/phz2), which are responsible for the 
synthesis of PCA (Cui et al., 2016). It has been reported by Mavrodi et al. that the two phenazine 
gene operons of P. aeruginosa are 98% identical in DNA level, but differ distinctively in their 
promoter regions. The regulatory genetic element las box is present in the promoter region of 
the phz1 operon, by which the quorum-sensing regulators LasR and/or RhlR recognize their 
target genes to initiate quorum-sensing-controlled gene expression. In contrast, for phzA2, the 
las box is not present in the promoter region (Mavrodi et al., 2001; Mavrodi et al., 2010). 
Furthermore, the two operons are also containing dissimilarities at DNA sequence level within 
phzA1B1 and phzA2B2, while the regions from phzC to phzG of both operons are highly identical 
(Recinos et al., 2012). Therefore, both operons of phenazine genes from P. aeruginosa PAO1 
and PA14 were deeper evaluated in this study. Base on the amino acid sequence comparison, 
each gene of phenazine operon from P. aeruginosa PAO1 and PA14 are containing dissimilarities 
between strains and operons as it is shown in Figure 6. 
 
 
 
Figure 6: Amino acid sequence similarity of phenazine operon 1 and 2 in P. aeruginosa PAO1 and PA14 (Mavrodi 
et al., 2001; Recinos et al., 2012) 
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1.6 Scope and outline of the thesis 
The purpose of this project is to develop an efficient engineered P. putida biocatalyst for 
oxygen-limited bioelectrochemical production, by employing phenazine electron shuttling to an 
anode as the main electron transfer pathway. Furthermore, to show the potential application, 
the heterologous production of rhamnolipids was combined with oxygen-limited phenazine 
redox balancing in the suitable P. putida host strain. The scope of the thesis is depicted in Figure 
7. 
 
 
Figure 7: Research work flow in this study 
 
Here in this study, we developed the concept of moving from an aerated to an oxygen-limited 
production process for rhamnolipids, where oxygen is only supplied in the headspace and/or via 
passive diffusion to prevent reactor foaming. With this approach, we aim to obtain the best 
heterologous P. putida phenazines producer for efficient biocatalysis in oxygen-limited BES. 
According to the motivation to generate P. putida KT2440 as an efficient biocatalyst for 
bioelectrochemical production, the following hypotheses have been proposed: 
 
1. Heterologous phenazine production in P. putida can be tuned and enhanced by testing 
the natural gene variability of the native hosts  
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2. The heterologous phenazines production can be coupled to rhamnolipid biosynthesis 
by generating plasmid-based genetic engineered P. putida.  
3. Oxygen-limited cultivations with redox balancing via phenazines in BES can be coupled 
to rhamnolipid biosynthesis. 
 
 
 
 
 
 
 
 
 
2 Chapter 2 
 
 
Materials and Methods 
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2.1 Strain engineering 
2.1.1 Bacterial strains, media preparation, and strain cultivation  
Pseudomonas putida strain KT2440 (DSM 6125) was used for heterologous expression of 
phenazine genes from P. aeruginosa PAO1 (DSMZ 19880) and PA14 (DSMZ 19882). Escherichia 
coli strain DH5α (New England Biolabs) has been used as intermediary cloning recipient. 
Standard strain cultivations were performed in 250 mL shake flasks using LB medium (Carl 
Roth®) with or without antibiotics as required and were incubated at 30 oC (P. putida) or 37 oC 
(E. coli). For P. putida characterization in well plates, shake flasks and BES experiment, the 
strains have been cultivated at 30 oC in Delft mineral salt medium (Hartmans et al., 1989), with a 
final composition (per L) of 3.88 g K2HPO4 (22 mM), 1.63 g NaH2PO4 (14 mM), 2.00 g (NH4)2SO4, 
0.1 g MgCl2.6H2O, 10 mg EDTA, 2 mg ZnSO4.7H2O, 1 mg CaCl2.2H2O, 5 mg FeSO4.7H2O, 0.2 mg 
Na2MoO4.2H2O, 0.2 mg CuSO4.5H2O, 0.4 mg CoCl2.6H2O, 1 mg MnCl2.2H2O, with 20 mM glucose 
(passive aeration) or 40 mM glucose (active aeration) and antibiotics as required (Kanamycin at 
50 μg/mL concentration or/and Gentamycin at 30 μg/mL concentration).  
 
2.1.2 Genetic engineering of P. putida for phenazine synthesis 
Table 1 gives an overview of the strains and plasmids used for construct generation. The 
plasmid harboring operon phzA1-G1 amplified from P. aeruginosa PAO1 genomic DNA (O1.phz1) 
was generated by Schmitz et al. The other three plasmids to synthesize PCA were newly 
constructed in this study; plasmid pBNTO1.phz2 harboring phzA2-G2 amplified from 
P. aeruginosa PAO1; the plasmid pBNT14.phz1 and pBNT14.phz2 harboring phzA1-G1 and 
phzA2-G2, respectively, amplified from P. aeruginosa PA14. For plasmids assembly, the Gibson 
assembly method was used and performed according to the manufacturer’s instruction (New 
England Biolabs-Gibson Assembly) (Gibson et al., 2009). Plasmid constructions were planned 
and conducted according to the New England Biolabs NEBuilder online tool 
(http://nebuilder.neb.com/). In Gibson cloning, DNA fragments are generated with special 
homologous primer-overlaps via polymerase chain reaction (PCR). Following vector 
linearization, all components were incubated with an enzyme mix, containing (i) a 5’-
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exonuclease (digesting of the 5’-ends of the fragments in order to enable the annealing of the 
homologues parts), (ii) a DNA polymerase (refilling the gaps by extending the 3’-ends) and (iii) a 
DNA ligase (for sealing of nicks). For the assembly reaction, the linearized vector (50-100 ng) 
was mixed with a 2-fold excess of the amplified inserts, which contained the homologous 
overhangs (primers 1-6 Table 2). For insert amplification, the Q5® High-Fidelity DNA polymerase 
(NEB) was used. After adding the Gibson assembly master mix, the mixture was incubated at 50 
°C for 30 minutes. The finished construct was transferred into chemically competent E. coli 
DH5 cells. 
Subsequently, all plasmids have been transformed into P. putida KT2440 via electroporation 
(Choi et al., 2006). For combined PCA and PYO synthesis, the best pre-selected strain producing 
PCA from each operon origin was transformed further with pJNN.phzM+S generated by Schmitz 
et al. Transformed cells were selected on LB agar plates with kanamycin (K, 50 μg/mL) for PCA, 
while for PCA & PYO producers LB agar plates with kanamycin (same concentration) and 
gentamycin (G, 30 μg/mL) were used. The constructs (Table 1) were verified using colony PCR, 
restriction digest analysis, and DNA sequencing with designed primers (Table 2). DNA plasmids 
sequencing analysis was performed using the Sanger sequencing method (GATC-Eurofins 
Genomics). The DNA sequencing products of the promoter and phenazine genes region were 
compared and verified with the reference plasmid map using Clone Manager Software. The 
successful expression of the phzA-G genes will show the PCA production by exhibiting yellow 
colour in Delft medium, while in combination with phzM+S genes, the bacterial culture will 
produce PCA and PYO appear in a greenish-blue color.   
 
Table 1: Bacterial strains and plasmids used for genetic engineering of P. putida for 
phenazine synthesis 
Strains/Plasmids Characteristics Source 
Strains 
P. aeruginosa PAO1 Wildtype DSMZ 
P. aeruginosa PA14 Wildtype DSMZ 
P. putida KT2440 Wildtype DSMZ 
P. putida O1.phz1      harboring plasmid pBNT.O1.phz1 (Schmitz et al., 2015) 
P. putida O1.phz2      harboring plasmid pBNT.O1.phz2 this study 
P. putida 14.phz1       harbouring plasmid pBNT.14.phz1 this study 
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P. putida 14.phz2 harboring plasmid pBNT.14.phz2 this study 
 
P. putida O1.phz1+ 
 
harboring plasmid pBNT.O1.phz1  
and pJNN.phzM+S 
 
(Schmitz et al., 2015) 
P. putida O1.phz2+ harboring plasmid pBNT.O1.phz2  
and pJNN.phzM+S 
this study 
P. putida 14.phz1+ harbouring plasmid pBNT.14.phz1  
and pJNN.phzM+S 
this study 
P. putida 14.phz2+ harbouring plasmid pBNT.14.phz2  
and pJNN.phzM+S 
this study 
E. coli DH5α  fhuA2 (argF-lacZ)U169 phoA  
glnV44 80 (lacZ)M15 gyrA96 recA1  
relA1 endA1 thi-1 hsdR17 
NEB 
Plasmids 
pBNT ORI: ori/IHF for replication in E. coli and 
Pseudomonas; Kanamycin resistance-
cassette, salicylate-inducible nagR/pNagAa 
promoter 
 
pJNN ori RO1600 for Pseudomonas and ori CoIE1 
for E.coli; Gentamycin resistance-cassette, 
salicylate-inducible nagR/pNagAa promoter 
 
pBNT.O1.phz1 ORI: ori/IHF for replication in E. coli and 
Pseudomonas; Kanamycin resistance-
cassette, salicylate-inducible nagR/pNagAa 
promoter, phzA1-G1.PAO1 genes 
(Schmitz et al., 2015) 
pJNN.phzM+S ori RO1600 for Pseudomonas and ori CoIE1 
for E.coli; Gentamycin resistance-cassette, 
salicylate-inducible nagR/ pNagAa 
promoter, phzM+S.PAO1 genes 
(Schmitz et al., 2015) 
pBNT.O1.phz2 ORI: ori/IHF for replication in E. coli and 
Pseudomonas; Kanamycin resistance-
cassette, salicylate-inducible nagR/pNagAa 
promoter, phzA2-G2. PAO1 genes 
this study 
pBNT.14.phz1 ORI: ori/IHF for replication in E. coli and 
Pseudomonas; Kanamycin resistance-
cassette, salicylate-inducible nagR/pNagAa 
promoter, phzA1-G1. PA14 genes 
this study 
pBNT.14.phz2 ORI: ori/IHF for replication in E. coli and 
Pseudomonas; Kanamycin resistance-
cassette, salicylate-inducible nagR/pNagAa 
promoter, phzA2-G2. PA14 genes 
this study 
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Table 2: Primers used for genetic engineering of P. putida for phenazine synthesis  
No Primer Sequence 5’ 3’ Function 
1 phz2.O1-f GAAACAGGAGGTACCGCCTCGT
CGCCTAGC 
amplifying the phzA2-G2. 
PAO1 gene, with EcoR1 
restriction site of overlapping 
regions for Gibson assembly  
2 phz2.O1-r CCTCTAGACTCGAGGGCGGTTG
GATGGGTTC 
3 phz1.14-f CCGACGTCGCATGCTCCTTGCG
GTTATCCGCCATGAAAC 
amplifying the phzA1-G1. 
PA14 gene, with EcoR1 & 
Xba1 restriction site of 
overlapping regions for 
Gibson assembly 
4 phz1.14-r AGGAAACAGGAGGTACCGTCCT
ACGTATGAACAATGCGC 
5 phz2.14-f GCCCGACGTCGCATGCTCCTGG
GCTCCAAGGCCGCGTAG 
amplifying the phzA2-G2. 
PA14 gene, with EcoR1 & 
Xba1 restriction site of 
overlapping regions for 
Gibson assembly 
6 phz2.14-r ACAGGAAACAGGAGGTACCGG
GTTACAACTGGGTTTCAGGCGA
AAC 
7 CP-f GTCAACGCGAACATTTCC amplifying the part of phzG 
gene to ORI region of pBNT 
plasmid (colony PCR 
verification)  
8 CP-r CAACTGTTGGGAAGGGCGATCG
GTG 
9 Seq_1 GCACCGGACTCCATATC sequencing part of phzG gene 
to ORI region of pBNT 
plasmid 
10 Seq_2 CACCATGCGAGAGTACC sequencing part of ORI to 
Kanamycin resistance 
cassette of pBNT plasmid 
11 Seq_3 GCTGTGGCGGTTTATGG sequencing part of 
nagR/pNagAa promoter 
region of pBNT plasmid to 
part of phzA gene 
12 Seq_4 GATCCTCAAGGGCTATG sequencing part of phzA gene 
to part of phzB gene 
13 Seq_5 GCGGCATTCCCGAAATC sequencing part of phzB gene 
to part of phzC gene 
14 Seq_6 GTTCGCCTTGCTCTACC sequencing part of phzC gene  
15 Seq_7 CGACAACCGCAAGGAAG sequencing part of phzC gene 
to part of phzD gene 
16 Seq_8 CGATGATCGCCAAGCAG sequencing part of phzD gene 
to part of phzE gene 
17 Seq_9 CGCATCCGCATCTTCAC sequencing part of phzE gene 
18 Seq_10 CCATGATGGGCGTCAAC sequencing part of phzE gene 
to part of phzF gene 
19 Seq_11 CACTGGCAGAGCATTAC sequencing part of phzF gene 
to part of phzG gene 
19 
 
2.1.3 Tailoring heterologous rhamnolipid-producing P. putida with phenazine production 
Table 3 shows the plasmids and strains used in construct generation. The plasmids harbor the 
rhlA and rhlB genes amplified from P. aeruginosa PAO1 genomic DNA. For plasmid assembly, the 
Gibson assembly method was used and performed according to the manufacturer’s instruction 
(New England Biolabs-Gibson Assembly) (Gibson et al., 2009). The rhlAB genes were inserted 
into pJNN and pJNN.phzM+S plasmids to generate pJNN.rhlAB and pJNN.rhlAB.phzM+S, 
respectively. Subsequently, the pJNN.rhlAB and pJNN.rhlAB.phzM+S plasmids have been 
transformed into P. putida KT2440 via electroporation (Choi et al., 2006). The new strains 
named P. putida rhl and P. putida rhl-MS for further references. Transformed cells were 
selected on LB agar plates with gentamycin (G, 30 μg/mL).  
The constructs were verified using colony PCR, restriction digest analysis, and DNA sequencing. 
DNA plasmid sequencing analysis was performed using the Sanger sequencing method (GATC-
Eurofins Genomics). For verification, the DNA sequencing products of the promoter and 
rhamnolipid genes were compared with the reference plasmid map using Clone Manager 
Software. Primers used for DNA sequencing are described in Table 4. Cells were tested for gene 
expression on LB media containing antibiotic and pre-added autoinducer. Transformed cells 
were selected on LB agar plates with kanamycin (K, 50 μg/mL) and gentamycin (G, 30 μg/mL). 
Successful expression of the rhamnolipid production genes rhlAB was verified via HPLC (high-
performance liquid chromatography).  
Subsequently, pBNT14.phz2 plasmid has been transformed into P. putida rhl and P. putida rhl-
MS via electroporation (Choi et al., 2006). The new strains named P. putida rhl-pca for PCA & 
rhamnolipid producer, and P. putida rhl-pyo for PCA, PYO, & rhamnolipid producer for further 
references. Transformed cells were selected on LB agar plates with kanamycin (K, 50 μg/mL) and 
gentamycin (G, 30 μg/mL). Successful expression of the rhamnolipid production genes rhlAB and 
phenazine/s were verified via HPLC.  
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Table 3: Bacterial strains and plasmids used for tailoring heterologous rhamnolipid-
producing P. putida with phenazine production 
Strains/Plasmids Characteristics Source 
Strains 
P. aeruginosa PAO1 Wildtype DSMZ 
P. aeruginosa PA14 Wildtype DSMZ 
P. putida 14.phz2 harboring plasmid pBNT.14.phz2 this study 
P. putida rhl      harboring plasmid pJNN.rhlAB this study 
P. putida rhl-pca harboring plasmid pBNT.14.phz2  
and pJNN.rhlAB 
this study 
P. putida rhl-MS harboring plasmid pJNN.rhlAB.phzM+S  this study 
P. putida rhl-pyo harboring plasmid pBNT.14.phz2  
and pJNN.rhlAB.phzM+S 
this study 
E. coli DH5α fhuA2 (argF-lacZ)U169 phoA glnV44 80 
(lacZ)M15 gyrA96 recA1 relA1 endA1 thi-1 
hsdR17 
New England 
Biolabs 
P. putida SK1 genome integrated rhlAB operon into the  
16S rDNA sequence (the initial study of the 
anaerobic flask experiment) 
(Kruth, 2017) 
Plasmids 
pJNN.rhlAB ori RO1600 for Pseudomonas and ori CoIE1 for 
E.coli; Gentamycin resistance-cassette, 
salicylate-inducible nagR/pNagAa promoter, 
rhlA and rhlB genes (P. aeruginosa PAO1) 
this study 
pJNN.rhlAB.phzM+S ori RO1600 for Pseudomonas and ori CoIE1 for 
E.coli; Gentamycin resistance-cassette, 
salicylate-inducible nagR/pNagAa promoter, 
phzM, phzS, and rhlA and rhlB genes 
(P. aeruginosa PAO1) 
this study 
pBNT.14.phz2 ORI: ori/IHF for replication in E. coli and 
Pseudomonas; Kanamycin resistance-cassette, 
salicylate-inducible nagR/pNagAa promoter, 
phzA2-G2 genes (P. aeruginosa PA14) 
this study 
  
21 
 
Table 4: Primers used for tailoring heterologous rhamnolipid-producing P. putida with 
phenazine production 
No Primer Sequence 5’ Function 
1 rhlAB-f GTACCGAATTCCTCGAGTGGGCTC
AACCTGGGAACTG 
amplifying the rhlAB.PAO1 gene, 
with Xba1 restriction site with 
overlapping regions for Gibson 
assembly to pJNN plasmid 
2 rhlAB-r CCGACGTCGCATGCTCCTCACCGCT
ACACAGGAAATTC 
3 rhlAB.MS-f GTCTTTTTTCGGCCGCGTACCAGGA
GGAGAGATG 
amplifying the rhlAB.PAO1 gene, 
with Xba1 restriction site with 
overlapping regions for Gibson 
assembly to pJNN.M+S plasmid 
4 rhlAB.MS-r CTGGATCTGGCCTAGGACTCTAGA
ATTCAGGACGC 
5 CP.rhlAB-f AGATGCGGCGCGAAAGTCTG amplifying the part of rhlA gene 
to promoter nagR/pNagAa 
region of pJNN plasmid (colony 
PCR verification)  
6 CP.rhlAB-r CGCGCCTGCTCGTATTCGCC 
7 CP.M+S.rhlAB-f CTAGGCCAGATCCAGCGG 
 
amplifying the part of rhlA gene 
to promoter nagR/pNagAa 
region of pJNN.M+S plasmid 
(colony PCR verification) 
8 CP.M+S.rhlAB-r GCGGCCGAAAAAAGACCCGC 
9 Seq_rhlA TGGCCGAACATTTCAACGTG Sequencing the rhlA gene region  
10 Seq_rhlB CTGTTCGACGGCAGTATCCC sequencing the rhlB gene region  
 
Eight clones of transformed P. putida, which were confirmed to produce both mono-
rhamnolipid and phenazine/s, were tested in triplicates for aerobic strain characterization and 
evaluation, as described in section 2.1.5. 
 
2.1.4 Plasmid sustainability experiments to determine the strain stability  
To confirm whether the P. putida rhl-pca strain was still harboring the two plasmids expressing 
rhamnolipids and PCA, during the cultivation in the BES reactor, reactor samples were plated for 
cell counts at day 3, 6, and 9. They were diluted at the range of 10-2 – 10-6, then 100 µL of the 
diluted sample was streaked on the LB plate containing 50 μg/mL of kanamycin only (selection 
for pBNT.14.phz2), LB plate containing 30 μg/mL of gentamycin only (selection for 
pBNT.14.phz2), LB plate containing both of kanamycin and gentamycin (selecting for both 
plasmids), and LB plate without antibiotics (no selection = all viable cells). The plates were 
incubated at 30 oC overnight. The number of bacteria counted from the plate was expressed in 
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CFU/mL (CFU = colony-forming unit). Counts on plates with antibiotics (indicating colonies 
containing the plasmids) were related to the total cell counts on plates without antibiotics. 
 
2.1.5 Aerobic strain characterization and evaluation 
For evaluation of phenazine and/or rhamnolipid production, eight clones of each constructed 
strain were tested in triplicates in the multiplexed cultivation platform micro cultivation  
(CR1424d, EnzyScreen, Heemstede, The Netherlands), using 24 square-well plates filled with 5 
mL Delft medium, 20 mM glucose, and supplemented with 50 μg/mL Kanamycin and/or 
30 μg/mL Gentamycin. While the aerobic shake flask experiments were performed in 250 mL 
Erlenmeyer flasks; filled with 25 mL Delft medium. Both of the cultivations were starting at a 
uniform inoculation OD600 of 0.1. After three hours of incubation, 0.1 mM (for phenazine 
production) and 1 mM for rhamnolipid production) sodium salicylate was added as an inducer 
for gene expression. The incubation temperature was 30 oC, and the shaking frequency was 224 
rpm (multiplexed cultivation) or 200 rpm (shake flasks experiment). The clone with the best 
growth behavior coupled with the best phenazine production of each constructed strain, during 
multiplex cultivation, was selected and further characterized in aerobic shake flasks- as well as 
BES experiments.  
 
2.1.6 Anaerobic strain characterization and evaluation 
To understand the effect of phenazines on the mono-rhamnolipid producing P. putida, a 
controlled study has been conducted. Here, the P. putida SK1 (genome integrated strain; Table 
3) was cultivated in anaerobic serum bottles with artificial phenazine addition. The P. putida SK1 
strain was cultivated in serum bottles (100 mL of Delft media in 220 mL bottles) closed with 
butyl septum and tightened with an aluminum cap. During initial growth, the P. putida SK1 + 
PYOsynth (~15 µg/mL) and P. putida SK1 + PCAsynth (~15 µg/mL,) were cultivated at 80 rpm, until 
the end of growth experiment (triplicate). The samples were taken once per day and measured 
for growth, synthetic phenazine concentration, and mono-rhamnolipid production. 
 
23 
 
2.2 Bielectrochemical experiments 
2.2.1 Oxygen-limited bioelectrochemical system experiments 
Single chamber glass BES reactors (500 mL working volume) equipped with a water jacket for 
temperature control were used (Figure 8). The integrated three-electrode set-up included: (i) a 
156.32 cm2 graphite comb of high grade graphite (EDM-3, Novotec) as WE (anode), (ii) a 
49.22 cm2 graphite block as CE (cathode), and (iii) a Ag/AgCl, saturated KCl electrode (192 mV 
vs. SHE at 30 oC, pH 7) as RE. The BES reactor experiments were performed at 30 oC at 200 rpm 
stirring with a magnetic stirrer, and potentiostatically controlled by a potentiostat (VMP3, 
BioLogic) at 0.2 V vs. RE. The electrical currents signal was recorded continuously, including 24 h 
of blank media measurement. Sampling for determination of optical density at 600 nm, pH and 
HPLC analysis were performed daily, following inoculation. The duplicate BES reactor 
experiments were performed under two types of oxygen-limited condition: (i) active aeration 
(AA), in which the active aeration was applied via a sparger at 30 mL/minute flow rate for 
48 hours, followed by passive aeration via two opened vent filters, and (ii) passive aeration (PA), 
in which only passive aeration via opened vent filters (~50 ppb dissolved oxygen) was applied 
for the entire experiment.   
(a)            (b) 
 
(c)   (d)   
 
Figure 8: Image of bioelectrochemical reactors used in this study (a) Active aeration set-up (b) Passive aeration 
set-up (c) P. putida 14.phz2+ produced PCA and PYO indicated by blue pigment in the grown culture (d) 
P. putida 14.phz2 produced PCA indicated by yellow pigment in the grown culture. 
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2.2.2 Bioelectrochemical production of rhamnolipids under the oxygen-limited condition 
The single-chamber reactors described in section 2.2.1 were applied in this experiment. To 
provide the best conditions for bioelectrochemical production of rhamnolipids, several different 
set-ups of BES experiments (triplicate) have been conducted as described in Table 5. The 
triplicate BES reactor experiments were performed under several types of oxygen-limited 
conditions: (i) active aeration via a sparger at 30 mL/minute flow rate for 48 hours, followed by 
either, passive aeration via two open vent filters (AA) or continued active aeration at 50 
mL/minute (AA+). (ii) Passive aeration (PA), via open vent filters, applied for the entire 
experiment. 
Table 5: Bioelectrochemical production of rhamnolipid set-ups 
Strains Set up (aeration mode, the presence of electrode) 
P. putida rhl     AA, without and with electrodes (triplicate) 
PA, with electrodes (single) 
P. putida rhl-pca AA, without and with electrodes (triplicate) 
AA, with carbon cloth electrode as WE: 400 cm2(duplicate) 
 AA+, with electrodes (triplicate) 
 AA+, with electrodes (single), plasmid sustainability experiment  
 PA, with electrodes (triplicate) 
 PA, with electrodes (triplicate, repetition experiment), plasmid 
sustainability experiment 
 
2.3 Analytical methods 
2.3.1 Bioinformatics analysis 
Sequences and annotations of Pseudomonas aeruginosa PAO1 (assembly: GCA_000006765.1) 
and Pseudomonas aeruginosa PA14 (assembly: GCA_000014625.1) have been obtained from 
GenBank (Benson et al., 2005). Each strain contains two main operons of seven almost identical 
genes each, organized in an operon for PCA production. All these genes have been compared 
individually by multiple protein alignment, and the entire operons (excluding the promoter) 
have been compared by multiple nucleotide alignment. Clustal Omega 1.2.4 has been used to 
perform the alignments (Sievers & Higgins, 2018; Sievers et al., 2011). To detect changes 
between the codon usage among genes in the four operons, codon adaptation indices (Sharp & 
25 
 
Li, 1987) have been calculated for all genes using an index previously generated for 
Pseudomonas putida KT2440 (assembly: GCA_000007565.2). All calculations are performed 
using Biopython 1.72 (Cock et al., 2009). For all proteins involved in phenazines production 
(except PhzF and PhzM due to full sequence identity), a 3D-model has been created by 
homology modeling using MODELLER (Webb & Sali, 2014). All structures have been predicted in 
the same way, including those with an experimentally determined structure, to avoid bias. 
Models have been built as homodimers, except PhzS, which has been built as a monomer. The 
predicted protein structures have been superimposed and displayed using UCSF Chimera 
(Pettersen et al., 2004). RMSD (root-mean-square deviation of atomic positions) has been 
calculated to measure the difference between structures. Plots for codon adaptation index 
comparison and operon analysis have been created using RStudio (RStudio_Team, 2015). 
 
2.3.2 Analysis of sugar metabolites 
Analysis of glucose and secreted metabolites was performed using HPLC equipped with a 
300×8.0 mm polystyroldivinylbenzol copolymer separation column (CS-Chromatographie), a 
UV/VIS detector at 210 nm and a refractive index (RI) detector at 35 °C. The separation was 
achieved at 60 °C with 5 mM sulphuric acid mobile phase at 0.8 mL/min isocratic flow rate. 
Analytical grade glucose, 2-ketogluconate, gluconate, and acetate (Carl Roth®) were used as 
standard solutions. 
 
2.3.3 Phenazine analysis 
The quantification of phenazines was performed using HPLC with a C18 column (Waters 
Corporation) equipped with a photodiode array UV/VIS detector (LC-168, BecKann), which 
detected and quantified the PCA at 366 nm and PYO at 280 nm. Separation was achieved with a 
gradient of 0.1 % trifluoroacetic acid (TFA) in acetonitrile (solution A) and 0.1 % TFA in water 
(solution B) as mobile phase (with solution A at 15 % for 2 min, 100 % for 15 min, and 5 % for 
3 min) at a flow rate of 0.8 mL/min and a column temperature of 20 °C (Kern & Newman, 2014). 
Analytical grade PCA (Princeton Biomolecular) and PYO (Cayman Chemical) were used as 
standard solutions of phenazines. 
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2.2.1 Rhamnolipid analysis 
The quantification of rhamnolipids was performed using reversed-phase high-performance 
liquid chromatography (RP-HPLC) elucidated in a NUCLEODUR C18 Gravity column (Macherey-
Nagel GbH & Co. KG, Düren, Germany) (dimensions: 150x4.6 mm; particle size: 3 mm). The HPLC 
system Ultimate 3000 was equipped with a Corona-charged aerosol detector (CAD) (Thermo 
Fisher Scientific Inc., Waltham, MA, USA). The flow rate was 1 mL/min at 40 °C column oven 
temperature. Separation was achieved with a gradient of 100 % acetonitrile (eluent A) and 
ultra-pure water containing 0.2 % (v/v) formic acid (eluent B) as buffers (with eluent A at 70 % 
for 9 min, 100 % for 3 min, and 70 % for 3 min) (Tiso et al., 2016). Analytical grade of 
rhamnolipids consists of mono-rhamnolipids and di-rhamnolipids (C8-C12 congeners) (Sigma-
Aldrich/AGAE Technologies) was used as standard solutions of rhamnolipids.  
 
2.3.4 Rhamnolipid detection using thin-layer chromatography (TLC) 
To verify the presence of rhamnolipids produced in the BES reactor, especially when the 
rhamnolipid concentration detected by HPLC was below 100 mg/L, TLC was applied. The 
samples from the reactors were extracted using ethyl acetate, in the ratio of 1:1 compared to 
the sample volume (3-5 times washed). The samples were subsequently evaporated using rotary 
dryer Scan speed 40™ connected to the SCANVAC Cooling Trap (LaboGene ApS, Lynge, 
Denmark) at 1400 rpm and 45 °C, for one hour. The dried rhamnolipid samples were dissolved 
in 20 µL ethanol. All of the solutions were spotted on silica 60 TLC-plate (Macherey-Nagel, 
Düren, Germany). As a standard solution, 5 µL of a 0.1 % commercial rhamnolipid extract R90™ 
containing mono- and di-rhamnolipid (AGAE Technologies LLC, Corvallis, USA) was spotted as 
well. The running buffer was a mixture of chloroform, methanol, and acetic acid in the ratio of 
65:15:2. For the visualization of the rhamnolipids, the TLC plate was layered with a solution 
mixture of acetic acid, sulfuric acid, and anisaldehyde in the ratio of 10:0.2:0.1. The TLC plate 
was incubated at >100 °C using the hot air gun (Einhell, Landau, Germany) until the bands 
became visible. The standard rhamnolipid mixture, as well as the samples, which contained 
rhamnolipids, were stained yellow by anisaldehyde.  
 
 
 
 
 
 
3 Chapter 3 
 
 
Results and Discussions 
28 
 
3.1 Boosting heterologous phenazine production in Pseudomonas putida 
KT2440 through the exploration of the natural sequence space 
 
A version of this chapter is ready to be submitted for publication with the following distribution 
of work of the co-authors:  
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wrote the manuscript 
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phenazine synthesis genes/proteins 
Lars M. Blank1  – co-supervised the work, discussed the results and revised the 
manuscript 
Miriam A. Rosenbaum2,3*  – conceived the work, planned the experiments, discussed the 
results and revised the manuscript 
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3.1.1 Summary 
Phenazine-1-carboxylic acid (PCA) and its derivative pyocyanin (PYO) are potential natural redox 
mediators in bioelectrochemical systems. The native producer Pseudomonas aeruginosa 
harbors two identical structured operons in its genome, which encode the enzymes responsible 
for PCA synthesis (phzA1-G1 (operon 1), phzA2-G2 (operon 1)). To optimize heterologous 
phenazines production in Pseudomonas putida KT2440, we compared PCA production from 
both operons originating from P. aeruginosa strain PAO1 (O1.phz1 and O1.phz2) as well as from 
P. aeruginosa strain PA14 (14.phz1 and 14.phz2). Comparisons of phenazine synthesis and 
bioelectrochemical activity were performed between heterologous constructs with and without 
the combination with the genes phzM and phzS required to convert PCA to PYO. Despite a high 
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amino acid homology of all enzymes of more than 97 %, P. putida harboring 14.phz2 was found 
to produce 4-times higher PCA concentrations (80 μg/mL), which resulted in 3-times higher 
current density at maximum (12 µA/cm2) compared to P. putida 14.phz1. The respective 
PCA/PYO producer containing 14.phz2 was the best producer with 80 μg/mL of PCA, 11 μg/mL 
of PYO, and 22 µA/cm2 of maximum current density. To elucidate the reason for this superior 
performance, a detailed structure comparison of the PCA-synthesizing proteins has been 
performed. The here presented characterization and optimization of these new strains will be 
useful to improve electroactivity in P. putida for oxygen-limited biocatalysis.  
3.1.2 Introduction 
One group of the redox compounds studied for natural MET are microbial phenazines, which 
are produced by Pseudomonas species, especially by Pseudomonas aeruginosa. The complex 
regulatory network of phenazine synthesis and the pathogenic nature of P. aeruginosa limit the 
application of phenazine redox mediation with this host for specific biotechnological 
applications (Venkataraman et al., 2011). Thus, to avoid P. aeruginosa as microbial host of 
phenazines production, the utilization of a non-pathogenic species would be an advantage for 
heterologous phenazines production and future biotechnological utilization. One of the non-
pathogenic Pseudomonas species, which has emerged as a versatile recombinant host is 
Pseudomonas putida KT2440 (Wackett, 2003). This host stands out because of the availability of 
extensive genetic and intrinsic metabolism information, combined with its tolerance to many 
chemical and biochemical substances. Therefore, it has been very useful as a production host of 
various valuable compounds (Loeschcke & Thies, 2015). 
As it has been described in Chapter 1, BES is also a device that can be applied in the bioprocess 
of platform chemicals production. To develop an efficient P. putida biocatalyst for 
bioelectrochemical production, it is necessary to explore further and optimize the heterologous 
production of phenazine. The work conducted by Bosire et al. showed for several carbon 
sources that P. aeruginosa PA14 produced more phenazines and resulting anodic currents than 
P. aeruginosa PAO1 in oxygen-limited BES. It is, therefore, clear that the phenazine production 
in P. aeruginosa is strain-dependent (Bosire et al., 2016). 
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Based on the successful initial proof-of-principle study has been reported in our lab 2015 
(Schmitz et al., 2015), the heterologous production of phenazine in P. putida has been improved 
further. The original producer of phenazines, P. aeruginosa, encodes for two homologous 
operons; phzA1-G1 (operon phz1) and phzA2-G2 (operon phz2), which are responsible for the 
synthesis of PCA. Although the two phenazine operons of P. aeruginosa are 98% in DNA level 
identical (97% in amino acid level), they differ distinctively in their promoter regions. Moreover, 
it has been revealed by Mavrodi et al. that the two operons contain dissimilarities at DNA 
sequence level within phzA1B1 and phzA2B2, while the regions from phzC to phzG of both 
operons are highly identical (Mavrodi et al., 2001). Base on the amino acid sequence 
comparison, each gene of phenazine operon from P. aeruginosa PAO1 and PA14 are containing 
dissimilarities between strains and operons, as it has been described in Figure 6 of Chapter 1. 
Hence, the heterologous expression of those two operons might be markedly different as well.  
Therefore, in this study, we generated new strains of P. putida expressing phenazine genes from 
three different gene sources as follows; P. aeruginosa PAO1 (operon 1) and P. aeruginosa PA14 
(operons 1 and 2) to produce PCA (Supplementary information Figure S1). Those three new 
constructs were compared with the performance of the already existing constructs originating 
from P. aeruginosa PAO1 operon 1 (Schmitz at al., 2015). The PCA-producing P. putida strains 
were combined further with the phzM+S plasmid to produce PYO. All phenazine producer 
strains were characterized in two different oxygen-limited conditions BES; 48 hours active 
aeration then subsequently switched to passive aeration and fully passive aeration. With this 
approach, we aim to obtain the best heterologous P. putida phenazines producer for efficient 
biocatalysis under oxygen-limited condition BES.  
  
31 
 
3.1.3 Results and discussions 
 
3.1.3.1 Phenazine gene origin determines the phenazine synthesis capacity in P. putida 
In an initial study, we transferred the capacity to synthesize the phenazines PCA and PYO from 
the pathogen P. aeruginosa into the GRAS (“generally recognized as safe”) organism P. putida 
KT2440 (Schmitz et al., 2015). The gene origins in that work came from P. aeruginosa strain 
PAO1 (i.e., O1.phz1 and phzM+S). Since it has been revealed in subsequent work that phenazine 
synthesis is much more active in P. aeruginosa strain PA14 compared to PAO1 (Bosire et al., 
2016), the specific genetic origin effects on heterologous phenazine production are here 
evaluated further. Each P. aeruginosa strain contains two strongly homologous copies of a 7-
gene operon responsible for PCA synthesis (O1.phz1 and O1.phz2 versus 14.phz1 and 14.phz2) 
and each of these operons without their native promotor regions was inserted into the 
inducible plasmid pBNT. Since the  PhzM protein shares 100% amino acid identity, while the 
PhzS protein shares 99% amino acid identity in the two strains (without impact on the active site 
of the protein) (Supplementary information Figure S2), the original plasmid construct for PYO 
synthesis (pJNN.phzM+S) with the genes originating from strain PAO1 was not changed in this 
study.  
The comparison of phenazine synthesis of a strain version carrying only the PCA-production 
genes and the combination with the phzM+S genes also to synthesize PYO was studied 
(indicated by “+” after the construct name, e.g., P. putida O1.phz1 makes only PCA, and P. 
putida O1.phz1+ makes PCA and PYO). For each construct, eight colonies were picked from agar 
plates after transformation and compared in parallelized growth experiments on a micro-
cultivation platform regarding the growth and yellow (PCA) or blue (PYO) pigment production 
(Figure 9 and Figure 10).  
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Figure 9: Growth curve (a) vs. PCA production (b) of eight individual clones of P. putida O1.phz1, O1.phz2, 14.phz1, 
and 14.phz2 in the micro cultivation experiment (triplicates for each). For this cultivation platform, the 
“green value” is the output signal for biomass density. The star symbol indicates the selected clone to be 
characterized in the flask & BES experiment. 
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Figure 10: Growth curve (a) vs. PCA & PYO production (b) of eight clones of P. putida O1.phz1+, O1.phz2+, 
14.phz1+, and 14.phz2+ in the micro cultivation experiment (triplicates for each). For this cultivation 
platform, the “green value” is the output signal for biomass density. The star symbol indicates the 
selected clone to be characterized in the flask & BES experiment. 
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For a more quantitative evaluation of phenazine synthesis, the best clone of each construct in 
the micro-cultivations was further cultivated in fully aerobic shake flask experiments (triplicate) 
(Figure 11 and Figure 12).  
 
 
Figure 11: Growth curve (a) vs PCA production (b) of the selected P. putida O1.phz1, O1.phz2 (both top graphs), 
14.phz1, and 14.phz2 (both bottom graphs) clone in the shake flask experiment (triplicates). 
 
The strain constructs P. putida 14.phz2, and 14.phz2+ showed the most intense color formation 
compared to other strains (Figure 13) with the maximum phenazine quantification results 
shown in Figure 13b. The P. putida O1.phz1 strain was found to be the lowest PCA producer 
(23.34 ± 1.06 µg/mL), and P. putida 14.phz1+ was identified to be the lowest PCA&PYO producer 
(5.86 ± 0.30 µg/mL and 0.60 ± 0.15 µg/mL, respectively). In comparison to the P. putida O1.phz1 
strain, the expression of the 14.phz1 operon alone (without phzM+S) worked well to produce 
PCA at 79.79 ± 9.09 µg/mL. It showed that PCA production of P. putida expressing the 14.phz1 
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operon was higher than with the O1.phz1 operon. However, the combination of both plasmids 
in P. putida O1.phz1+ to produce PCA & PYO (8.50 ± 2.43 µg/mL & 12.10 ± 1.25 µg/mL, 
respectively) worked better than with P. putida 14.phz1+, although the growth curve of P. 
putida 14.phz1+ was similar compared to P. putida O1.phz1+ (Figure 12a). In P. putida 14phz.1+, 
the presence of the phzM+S genes negatively impacted the PCA synthesis, which resulted in low 
PYO production.  
 
 
Figure 12: Growth curve (a) vs PCA & PYO production (b) of the selected P. putida O1.phz1+, O1.phz2+ (both top 
graphs), 14.phz1+, and 14.phz2+ (both bottom graphs) clone in the shake flask experiments (triplicates). 
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Figure 13: Heterologous expression of phz genes in P. putida KT2440. (a) P. putida cultures (from left to right) 
expressing O1.phz1, O1.phz2, 14.phz1, and 14.phz2 gene for PCA synthesis (top) and with combination of 
phzM+S genes for PCA & PYO synthesis PCA&PYO (bottom); (b) Phenazine production of engineered 
P. putida strains in triplicate shake flask experiments (fully aerobic), whereby the ‘+’ in the strain 
designation indicates presence of phzM+S to convert PCA to PYO. 
 
Moreover, P. putida O1.phz2 with 29.50 ± 1.29 µg/mL produced more PCA than P. putida 
O1.phz1, although the growth curve of P. putida O1.phz2 was lower compared to the other PCA 
producers strain (Figure 11a). It seems the high capacity of phenazine protein synthesis caused 
the growth reduction in P. putida O1.phz2. Furthermore, the P. putida 14.phz2 strain was found 
to be the most active PCA producer (292 ± 4.58 µg/mL) and P. putida 14.phz2+ to be the most 
active PCA & PYO producer (16 ± 2.31 µg/mL and 33.96 ± 3 µg/mL, respectively). The growth 
curve of P. putida 14.phz2 was similar to P. putida O1.phz1 and 14.phz1. It showed that the 
phzA-G operon 2 from P. aeruginosa PA14 was more active to produce PCA compared to operon 
1. In P. putida 14.phz2+, although the PYO production was highest compared to the other 
strains, the PCA production was low. As the PCA production of the P. putida 14.phz2 strain was 
high, it was expected that P. putida 14.phz2+ would produce more PCA as well. However, we 
assumed that the two antibiotics burden also occurred in this strain caused low phenazines 
synthesis. And also, the presence of PYO may have a toxic effect on the cells since it is known to 
generate toxic oxygen radicals and therefore hinders the further PCA synthesis.  
Overall, the experiments conducted under fully aerobic flask showed that the PCA synthesis of 
P. putida expressing the phenazine genes (same strain origin) from operon 2 of P. aeruginosa 
was higher than from operon 1. Furthermore, it was revealed that PCA production of P. putida 
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expressing the phenazine genes from P. aeruginosa PA14 was higher compared to PAO1. On the 
other hand, for combined PCA & PYO production, the phenazine production was affected by 
either the metabolic burden of the two antibiotics applied and/or a restricted total phenazine 
production with increased levels of PYO, which shows toxic behavior at higher concentration 
through the formation of reactive oxygen species (Mentel et al., 2009). In general, it showed 
that under fully aerobic condition, phenazine synthesis in engineered P. putida is strain 
template- and operon-dependent. 
 
3.1.3.2 Phenazine gene origin determines performance in oxygen-limited BES  
The motivation for engineering P. putida to produce phenazines is driven by the idea to 
capacitate this obligate aerobic bacterium for biocatalysis in the oxygen-limited BES. Phenazine 
producing P. putida will be able to utilize phenazines as the reversible redox mediator for the 
anodic discharge of metabolic electrons. In the future, this oxygen-limited metabolism will be 
coupled with valuable compound production in the BES. To characterize the potency of P. 
putida strains synthesizing phenazines from different gene origin, the BES performance of each 
engineered strain variant has been evaluated. In Figure 14, the left column shows the strain 
performance in BES under active aeration, while the right column shows the performance in BES 
under passive aeration. In the upper part (Figure 14a,b and e,f), the BES performance of the 
construct originating from the PAO1 genes shown, while the BES performance of genes 
templates from PA14 are shown in the lower part (Figure 14c,d-g,h). Underactive aeration BES, 
the lowest PCA production and current generation were observed from P. putida O1.phz1, 
which only produced 9.38 μg/mL of PCA at maximum, corresponding to 1.68 µA/cm2 of current 
density until day 7. The BES performance of this strain was in accordance with the flasks 
experiment, in which P. putida O1.phz1 also showed the lowest production of PCA. It has been 
observed in a control experiment where ~17 μg/mL of synthetic PCA has been added to the 
P. putida KT2440 wildtype in an oxygen-limited BES, that the PCA concentration sustained in the 
reactor until the end of the experiment, i.e., was not degraded or absorbed to the electrode, 
and produced a current density up to 8.57 µA/cm2 (Figure 15a).  
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Figure 14: Heterologous phenazine production with P. putida under oxygen-limited conditions in a BES. Current 
densities generation and phenazine production of engineered P. putida KT2440 harbouring either phz 
operon 1 (blue curves) or operon 2 (black curves) originating from P. aeruginosa strains PAO1 (a, b and e, 
f) or PA14 (c, d, and g, h). The left side shows data from actively aerated BES experiments and the right 
side refers to purely passively aerated BES. The highest currents generation and phenazine production 
were obtained from the engineered P. putida carrying operon 14.phz2 under active aeration BES (Figure 
7.d). The BES data are means from biological duplicates. 
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Figure 15: BES cultivation of P. putida KT2440 (wildtype) under passive aeration conditions. Synthetic PCA (a) or 
PYO (b) was added (~17µg/mL) after 24 hours inoculation (day 1). 
Furthermore, by far the weakest PCA&PYO producer in actively aerated BES was P. putida 
14.phz1+, which only produced 2.71 μg/mL of PCA, 1.63 μg/mL of PYO and 4.74 µA/cm2 of 
maximum current density. This result also mirrored the feeble activity of the phenazine 
production of P. putida 14.phz1+ in the flasks experiment, where the combination of the 
14.phz1 genes with the phzM+S genes leads to an almost complete suspension of phenazine 
production. 
Moreover, the highest phenazine production and current generation were observed with 
P. putida 14.phz2, which produced 4-times higher PCA concentration, i.e., 80 μg/mL, resulting in 
3-times higher maximum current density of 11.77 µA/cm2 compared to the other PCA gene 
operons. Also, the combination of PCA & PYO produced with P. putida 14.phz2+ outperformed 
the other strains with 80 μg/mL of PCA, 11 μg/mL of PYO and 22.33 µA/cm2 of maximum 
current density. Again, the performance in oxygen-limited BES of this strain was in accordance 
with the aerobic flasks experiment. It was observed in this study that the presence of PYO as a 
soluble redox mediator compound in the BES is significantly increasing the electron shuttling to 
the anode. From control experiments with the P. putida KT2440 wild type with ~17 μg/mL of 
exogenous PYO added to an oxygen-limited BES, we know that the PYO concentration is not 
sustained over time, likely because of adsorption to the electrode (Figure 15b). However, here, 
we see a fairly stable concentration of PYO over the course of the experiment with a 
continuously increasing concentration of PCA. It means that PYO is continuously resynthesized 
from PCA when it is intrinsically produced.  
40 
 
Furthermore, in passively aerated BES, the lowest PCA production and current generation were 
observed from P. putida 14.phz1, which only produced 7.21 μg/mL of PCA and generated 
2 µA/cm2 of currents density. Also, in combination with phzM+S genes, P. putida 14.phz1+ was 
only able to produce 3.11 μg/mL of PCA and 0.65 μg/mL of PYO, resulted in 2.58 µA/cm2 of 
current density. On the other hand, P. putida 14.phz2 was confirmed as the best PCA producer 
also under passive aeration conditions, where it produced 21.09 μg/mL of PCA and, generated 
4.12 µA/cm2 of current density. Together with phzM+S genes, P. putida 14.phz2+ was able to 
produce 22.48 μg/mL of PCA and 10.29 μg/mL of PYO, resulting in 5.53 µA/cm2 of current 
density. 
Overall, the performance of the P. putida phenazine producing strains in oxygen-limited BES is 
well following the performance in flasks experiment. Also, it is confirmed for these cultivation 
conditions, that the phenazine synthesis in P. putida is strain origin- and operon-dependent. In 
direct comparison, the maximum produced amounts of PCA, however, are lower under oxygen-
limited conditions compared to fully aerobic shake flasks because of the restricted energy 
availability. Notably, for the active aeration BES scenario, where the reactors were aerated for 
the first 48 hours of growth to enable faster growth and cellular energy generation followed by 
completely passive aeration with vent filters, a remarkable activity for PCA production resulting 
in roughly 1/3 of the concentrations of the aerobic cultivation was observed. This PCA 
production continued throughout the passive aeration phase, confirming results from Schmitz 
et al. that stringently oxygen-limited conditions enable biosynthesis in P. putida if an anode is 
made accessible for metabolic electron discharge (Schmitz et al., 2015).  The concentration of 
PYO is not further increasing after switching from the active to the passive aeration phase 
because of the requirement of molecular oxygen for the enzymatic PYO synthesis. 
 
3.1.3.3 Phenazine gene origin affected the carbon substrate utilization capacity 
To further evaluate the metabolic activity of the phenazine producing P. putida strain under 
oxygen-limited conditions, we analyzed biomass formation, glucose consumption, metabolite 
production, and the efficiency of donating metabolic electrons derived from the substrate 
glucose the anode, which is measured as coulombic efficiency. Table 6 summarizes all results. 
We did not observe any strong biofilm formation with P. putida in our BES, and the evaluations 
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at OD600 are well suited to compare the growth performance of the strains. This is different from 
BES experiments with P. aeruginosa as described by Bosire et al., where we found very strong 
and variable biofilm formation in the experiments and a time-resolved estimation of growth was 
difficult (Bosire et al., 2016).  The best growth, with the highest OD600 of 2.45, was observed for 
P. putida 14.phz2 under active aeration which sustained throughout the stationary phase until 
day 11 after inoculation. The average OD600 for active aeration was 1.95 compared to 1.57 for 
passive aeration, reflecting the very stringent oxygen availability during passive aeration. The 
glucose consumption is shown as the percentage of the provided glucose, which was 40 mM in 
active aeration BES and 20 mM in passive aeration BES. Most cultures showed a glucose 
consumption of approximately 80 % for active and about 70 % for passive aeration. The highest 
value of 88 % was observed for P. putida O1.phz2+ under active aeration BES. Notably, the 
lowest glucose consumption of only ~40 % for both active and passive aeration was found for 
strain P. putida 14.phz1. It has been reported before that P. putida produces several organic 
acids, such as 2-ketogluconate, gluconate, and acetate as side products from glucose 
degradation under oxygen-limited conditions (Nikel et al., 2015; Schmitz et al., 2015). For most 
strains, side product formation in these experiments stayed fairly low in the range of 0.1 to 2.9 
mM. However, the best phenazine and most active current producer P. putida 14.phz2+ reached 
up to 4.80 mM gluconate. It is an exciting finding, since gluconate is a valuable biochemical 
product for industrial application, especially in food processing and pharmaceutical industry 
(Vandenberghe et al., 2018). This finding is also in line with bioelectrochemical studies of 
P. putida F1 with exogenous ferricyanide as an electron mediator, which shows a high efficiency 
of glucose to sugar-acid conversion under oxygen-limited BES conditions (Lai et al., 2016).  
The estimation of energy retrieved from the carbon source in BES can be calculated as 
coulombic efficiency (Sleutels et al., 2011). Table 2 shows that overall, the coulombic efficiency 
observed from all strains was low. However, the most active strains P. putida 14.phz2 and P. 
putida 14.phz2+ showed a significantly increased coulombic efficiency of up to ~6 % for both 
active and passive aeration. This result indicates that already small changes in the strain design 
for phenazine synthesis can improve not only phenazine production but also the efficiency of 
bioelectrochemical interaction of this strain. For a further improvement of phenazine based 
electron discharge to the anode as the extracellular metabolic electron acceptor, specific 
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knowledge about the involved biochemical and energetic reaction pathways is required. 
However, this information is neither available yet, for P. aeruginosa nor P. putida. Work is 
ongoing in our group to elucidate the specific phenazine electron transfer pathways and their 
integration into the energetic pathways of the microorganisms.  
In general, this study showed that P. putida expressing the phenazine gene origins from operon 
2 of P. aeruginosa strain PA14 with or without the combination with the phzM+S genes, either 
underactive or passive aeration, was able to convert the carbon source to biomass, metabolite 
production, and anodic currents in BES at a high level. In contrast, surprisingly, the P. putida 
14.phz1 strain showed the lowest level of carbon source utilization, biomass formation, 
metabolite production, and coulombic efficiency, either underactive or passive aeration BES. In 
combination with the phzM+S genes, the P. putida 14.phz1+ showed the same level of the 
carbon utilization to P. putida 14.phz1 strain. Overall, despite being highly homologous, we 
found that the specific gene origins play a crucial role in phenazine production and subsequently 
carbon source utilization and bioelectrochemical activity of P. putida in BES.  
Table 6: Summary of glucose and metabolite evaluation of oxygen-limited BES experiments 
(Data are means of biological duplicate) 
O2 Strains OD600 
max 
Glucose 
consumpt. 
(%) 
Gluconate 
(mM) 
2-Ketogluconate 
(mM) 
Acetate 
   (mM) 
Coulombic 
effic. (%) 
AA O1.phz1      1.91 78 0.15 0.89 - 1.34 
 O1.phz2      1.72 80 0.29 0.10 0.84 1.47 
 14.phz1       1.74 44 0.08 1.12 0.65 1.12 
 14.phz2 1.78 87 0.76 0.63 2.90 2.72 
 O1.phz1+ 1.90 63 0.59 2.30 1.53 1.45 
 O1.phz2+ 1.87 88 0.69 0.07 1.56 1.53 
 14.phz1+ 2.25 78 2.90 1.70 2.25 1.77 
 14.phz2+ 2.45 83 4.80 1.30 2.45 5.90 
 
PA O1.phz1      1.21 72 0.07 0.91 - 1.04 
 O1.phz2      1.73 68 0.42 0.70 0.99 2.05 
 14.phz1       1.02 39 1.91 0.55 1.38 0.77 
 14.phz2 1.88 79 0.05 0.47 0.59 5.40 
 O1.phz1+ 1.70 65 0.38 0.29 0.63 3.38 
 O1.phz2+ 1.71 68 1.50 1.25 - 2.89 
 14.phz1+ 1.54 81 0.17 0.29 - 1.45 
 14.phz2+ 1.79 46 0.04 1.89 1.46 5.89 
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3.1.3.4 Deciphering the effects of operon and strain origin for heterologous production of 
phenazine in P. putida  
To elucidate possible reasons for the difference in phenazine production capacity and resulting 
BES performance, we took a more in-depth look at the gene origins for PCA synthesis at DNA 
and protein level (Supplementary data Data S1). In all constructs, we omitted the native 
promoter region of the operons and cloned the genes in a uniform salicylic acid-inducible 
vector. Thus, any difference in performance and activity should be incorporated directly in the 
sequence information of the genes. All plasmids have been re-sequenced to confirm the 
correctness of the original sequence and exclude mutations. To obtain a deeper understanding 
of the gene characteristic and its impact to dictate the phenazine production, an in silico 
analysis of all genes origin used in this study has been conducted. Figure 16a-b shows the 
nucleotide alignment corresponding to two potential regulatory intergenic regions. These 
regions have enough length to allow the attachment of DNA-binding proteins, and they own 
ribosome binding sites (consensus sequence: 5’-AGGAGG-3’). The first regulatory element 
(Figure 16a) is located between the genes phzA and phzB. The RBS (ribosome binding sites) is 
slightly interrupted by a deletion in the operons 1 compared with operons 2, where the RBS are 
longer and more similar to the consensus sequence. It has been revealed that in the phenazine 
biosynthesis pathway, the PhzB protein plays an important role to accelerate the condensation 
of two molecules an of the intermediate product called 6-amino-5-oxocyclohex-2-ene-1-
carboxylic acid (AOCHC) in the PCA formation (Blankenfeldt & Parsons, 2014). Thus, changes in 
the efficiency of PhzB protein synthesis will significantly influence overall phenazine synthesis. 
Furthermore, the second regulatory element (Figure 16b) is located between the genes phzB 
and phzC. There is an insertion observed in the operon 1 from strain PA14. The RBS in this 
operon seems to be slightly longer, but it is almost identical to the other ones. Other intergenic 
regions presenting RBS (Supplementary data Data S2) were also detected, but no differences 
observed among them. Those regions are located between phzE and phzF as well as between 
phzF and phzG.  
Furthermore, one of the crucial aspects of the heterologous expression of specific genes is the 
fact that every organism is likely to prefer distinctive codons than others. In the genes of 
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different organisms, a non-random distribution of synonymous codons has been explicated by 
the comparative sequence analysis, the so-called codon bias (Quax et al., 2015). Instead of 
influencing the expression levels of protein, the codon bias is also affecting the protein folding 
and distinctive regulation of protein expression (Gingold et al., 2014; Pechmann & Frydman, 
2013). It has been revealed that among genes in one genome, the codon usage is varied. To 
detect changes between the codon usages among genes in the four operons, codon adaptation 
indices have been calculated for all genes using an index previously generated for P. putida 
KT2440 (Sharp et al., 2005). Counting the cases in which each operon has a best or worst result, 
Figure 16c plots have been created to give an overall idea about the potential expression 
success of these operons. According to the results, operon 2 of PA14 would tend to have a 
better expression compared with the other constructs. 
Moreover, a phylogenetic tree describing the relation between gene origins used in this study 
has been generated (Supplementary data Figure S3). It showed that the differences between 
operons are more prominent compared to the differences between strains. The amino acid 
comparison between operon 1 and 2, either in PAO1 or PA14, showed the same pattern. The 
overall amino acid alignment analysis indicated the biggest difference between operons 1 and 2 
in the PhzB protein (91% identical), followed by the PhzA protein (97% identical). However, our 
structure analysis showed that these differences in the amino acids, which are located at the N- 
and C-terminus on the outer sphere of the protein, are likely not affecting the protein function. 
In general, regarding the structural analysis, mostly small conformation changes are detected in 
most of the enzymes involved in phenazine synthesis (Supplementary data Figure S4-S8). These 
changes are mainly located in the N-terminus, C-terminus and nearby loop regions, which could 
be the target of post-translational modifications and therefore these regions may not be 
present in the mature protein. 
Nevertheless, in the protein, PhzE, relevant variations can be observed, which may be necessary 
in the activity of this protein (Figure 17). Structure differences are mainly occurring in PA14-
PhzE2, probably due to two unique amino acid exchanges, which are the substitution of Leucine 
to Phenylalanine and another Leucine to Isoleucine. Those amino acids located close to each 
other and close to the enzyme catalytic site where the substrate chorismate binds. These 
exchanges likely yield the conformational shift, which our analysis predicts. PhzE protein plays a 
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vital role in the phenazine synthesis since it is the first protein of the synthesis pathway. It 
catalyzes the formation of 2-amino-2-desoxyisochorismate (ADIC) from the central metabolic 
intermediate chorismate (Spraggon et al., 2001). Therefore, the specific changes in the active 
site of this enzyme in the gene origin PA14-phzE2 will likely have an impact on the overall 
phenazine synthesis and might be responsible for the superior performance of the 14.phz2 
operon for PCA synthesis. 
 
Figure 16: Nucleotide-based analysis of the phenazine operons. a) First regulatory element alignment overview. 
Deleted nucleotides are marked as a hyphen (-). Identical bases are marked as an asterisk (*). b) Second 
regulatory element alignment overview. Deleted nucleotides are marked as a hyphen (-). Identical bases 
are marked as an asterisk (*). c) Prediction of the expression tendency. Bars represent the number of 
times each operon has the highest or the lowest CAI. 
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Figure 17: Structural analysis of PhzE. a) PA14-PhzE2 is used as the reference for the alignment (blue). RMSD for 
PA14-PhzE1 (yellow): 1.056 Å. RMSD for PAO1-PhzE1 (green): 0.836 Å. PAO1-PhzE2 is identical to PAO1-
PhzE1. Unique amino acid changes regarding PA14-PhzE2 (p.[F231L; I266L]) are marked in purple. 
Substrate (chorismate) molecules are marked in yellow. b) Detail of the substrate-binding site vicinity. c) 
Detail of the unique amino acid changes in PA14-PhzE2 and location inside the structure. 
 
3.1.4 Conclusions 
The heterologous expression and comparative study of phenazine synthesis gene origins 
originating from two operons of P. aeruginosa strain PAO1 and PA14 in P. putida KT2440 
revealed their distinctive activity. The gene origin dictates phenazine synthesis activity under 
fully aerobic flask experiments and oxygen-limited BES conditions, also affecting carbon 
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utilization. In this study, the phzA-G operon 2 from P. aeruginosa PA14 (14.phz2) carrying strain 
was found to be the best phenazine producer. P. putida 14.phz2 stunningly produced 4-times 
higher PCA concentrations as well as the respective PCA/PYO amounts compared to the other 
PCA synthesis operons, which resulted in 3-times higher maximum current density and 5-times 
higher coulombic efficiency than for the others. Through deciphering potential sequence-based 
reasons for this superior function, it has been revealed that the 14.phz2 genes contained 
distinctive regulatory elements. 
Furthermore, the codon usage prediction, estimated by CAI, showed that operon 2 of strain 
PA14 differed, potentially supporting protein synthesis. Most importantly, for the PA14-PhzE2 
enzyme, the 3D-protein structure analysis showed two unique amino acid changes in PA14-
PhzE2 located close to the enzyme catalytic site where the substrate chorismic acid binds. This 
difference might promote higher PCA synthesis.  
Here we show that P. putida 14.phz2 is a promising candidate to be employed as a 
biocatalyst in an oxygen-limited BES. The electric current generation can now be coupled with 
the bioelectrochemical production of valuable compounds. Example compounds that can be 
tailored further with phenazine production are rhamnolipids. These compounds are glycolipid 
biosurfactants, which offer many benefits for industrial application, for example as bio-
detergent, bioremediation agent, and pharmaceutical additive agent. The production of 
rhamnolipid has been developed under fully aerobic conditions, in which the scale-up 
production using common bioreactors requires vigorous aeration. It causes strong growth 
medium foaming and reduces the yield, which is challenging to be overcome with conventional 
antifoam technologies (Beuker et al., 2016; Küpper et al., 2013). Hence a bioelectrochemical 
system involving phenazine as redox mediator could be applied as an alternative approach to 
produce foam-free rhamnolipids. Overall, the presented research findings will be useful to 
establish efficient, oxygen-limited biocatalysis of P. putida in BES.  
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3.2 Coupling the electroactive P. putida KT2440 with bioelectrochemical foam-
free rhamnolipids production 
*In this study, we used P. putida SK1 strain constructed by Kruth (Kruth, 2017) for control  
   experiments 
*The TLC experiment was assisted by Andreas Wittgens 
 
3.2.1 Summary 
Rhamnolipids are prospective microbial biosurfactants with eco-friendly properties. The 
metabolic engineering of Pseudomonas putida KT2440 as a recombinant host for rhamnolipid 
production has been already developed under aerobic conditions. However, costly aeration and 
the subsequent problems with strong reactor foaming are still technically challenging. Thus in 
this work, we are combining the phenazine-producing P. putida KT2440 with rhamnolipid 
production under the oxygen-limited condition in a bioelectrochemical system. For the first 
time, here we present the newly engineered P. putida rhl-pca strain harboring the rhlAB genes 
to synthesize mono-rhamnolipid (originating from Pseudomonas aeruginosa PAO1) with the 
phzA-G genes of operon two (originating from P. aeruginosa PA14) to synthesize phenazine-1-
carboxylic acid or PCA as an electron shuttle in BES. Furthermore, we generated another 
genetically engineered P. putida rhl-pyo strain harboring the rhlAB genes along with phzM+S 
genes (originating from P. aeruginosa PAO1) and phzA-G genes of operon two from 
P. aeruginosa PA14 to synthesize mono-rhamnolipid, PCA, and pyocyanin (PYO), respectively. 
The new strain of P. putida rhl-pyo produced a shallow concentration of mono-rhamnolipid 
during the fully aerobic experiment (flasks), i.e., only 50 ± 0.00 mg/L mono-rhamnolipid, 130.80 
± 16.83 µg/mL of PCA, and 33.96 ± 2.80 µg/mL of PYO after 72 hours cultivation. On the other 
hand, P. putida rhl-pca was able to produce both mono-rhamnolipid and PCA under fully aerobic 
condition, i.e., 152 ± 1.22 mg/L of mono-rhamnolipid and 122.27 ± 12.49 µg/mL of PCA after 72 
hours cultivation. The P. putida rhl-pca was tested further for bioelectrochemical production 
under oxygen-limited BES cultivation. We observed that P. putida rhl-pca did not produce any 
mono-rhamnolipid on the BES reactors with active aeration, either for 48 hours (AA) or 
continuously (AA+) during the cultivation. In contrast, under passive aeration (PA) with the most 
stringent oxygen level in the reactor, this strain was able to produce mono-rhamnolipid at 20.67 
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± 0.15 mg/L and 11.23 ± 0.78 μg/mL of PCA, which resulted in 8.07 ± 0.15 µA/cm2 of maximum 
current density at a polarized anode, during 10 days cultivation. This result showed that the 
newly engineered P. putida rhl-pca is capable of being employed as a biocatalyst for 
bioelectrochemical production of foam-free mono-rhamnolipid. Moreover, this work also 
revealed that it is possible to produce glycolipid surfactants under oxygen-limited BES reactor. 
3.2.2 Introduction  
Rhamnolipids are one of the best explored microbial glycolipid surfactants. This compound is 
offering eco-friendly characteristics such as biodegradable, causing low eco-toxicity effect, and 
can be produced from renewable resources (Faivre & Rosilio, 2010), which make this compound 
considered as a prospective biosurfactant to be expanded in industrial scale. However, the 
production of rhamnolipids from the native producers, especially from pathogenic bacterium 
P. aeruginosa, is controlled by complex quorum sensing regulation. Hence, the studies of using a 
non-pathogenic bacterium as a recombinant host for rhamnolipid production will be beneficial.  
As a biocatalyst, the metabolic engineering of P. putida KT2440 for rhamnolipid production has 
already been developed under aerobic condition (Wittgens et al., 2011). However, costly 
aeration and the subsequent problems with strong reactor foaming are still technically 
challenging to be overcome (Küpper et al., 2013). Furthermore, those mentioned technical 
challenges are also hindering the scale-up process in the industrial production of rhamnolipids 
(Beuker et al., 2016). To reduce the drawbacks of aerobic growth, we explore an alternative 
approach for rhamnolipid production using P. putida as a biocatalyst under oxygen-limited 
growth in the bioelectrochemical system or BES. BES enabled the production of various valuable 
compounds, even using biomass waste. This bioprocess potentially reduces greenhouse gases 
emission and conserves energy simultaneously (Steinbusch et al., 2010).  
The implementation of BES for rhamnolipid production is based on the successful heterologous 
production of phenazine redox mediators in P. putida. It was first reported by Schmitz et al. in 
2015 and has recently been further optimized by myself, as it has been described in Chapter 3.1 
(Schmitz et al., 2015). This work enabled a newly engineered strain of non-pathogenic, aerobic 
P. putida KT2440 (so-called as P. putida pPhz) to grow under oxygen-limited conditions in a BES 
through the electron discharge to an extracellular anode. All previous studies showed that the 
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best BES set up for phenazine and currents production is active aeration, in which the aeration 
via an air sparger was applied for 48 hours and then switched to passive aeration of the 
headspace until the end of cultivation. It has been revealed that during active aeration for 48 
hours, P. putida pPhz produced mainly PYO, then subsequently during the passive aeration, PCA 
was predominantly synthesized and responsible for sustaining the current generation. 
Specifically, I determined in the previous chapter that the most successful heterologous 
phenazine production in P. putida was achieved with P. putida 14.phz2 to produce PCA 
compared to all other tested constructs. This strain also showed promising performance under 
oxygen-limited conditions in BES reactors.  
To gain information on the overall performance and possible toxic effects of phenazine-based 
electron discharge in a rhamnolipid producing strain, we initially evaluated the growth of 
rhamnolipid producer strain in anaerobic cultivation. We worked with a genomic-integrated 
mono-rhamnolipid-producing P. putida SK1. The rhlAB genes in this strain were inserted in the 
16S rRNA gene sequence of genomic DNA. In this anaerobic cultivation simulation, we added 
the synthetic commercially PCA and PYO and observed the growth as well as the mono-
rhamnolipid production of the strain. 
Furthermore, to evaluate the actual capacity of phenazine-based redox balancing in an oxygen-
limited BES, this strain was now coupled with two newly constructed plasmids for heterologous 
production of rhamnolipids in P. putida (Supplementary information Figure S9). Furthermore, 
the production of both phenazine and mono-rhamnolipid from both strains were evaluated 
under fully aerobic condition (triplicate flasks experiment). The most potential strain that 
produced adequate amounts of both phenazine and mono-rhamnolipid has been further 
assessed for bioelectrochemical production under active aeration for 48 hours followed by 
passive aeration (AA), active aeration continuously (AA+), and passive aeration from the start 
(PA) in BES reactors (biological triplicates).  
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3.2.3 Results and Discussions 
3.2.3.1 Tailoring heterologous mono-rhamnolipid synthesis with phenazine production in 
P. putida 
The first new plasmid constructed in this study was a salicylate inducing-promoter pJNN plasmid 
carrying rhlAB genes, expressing mono-rhamnolipid. The second plasmid was the modification 
of the existing pJNN.phzM+S plasmid constructed by Schmitz et al. in which the rhlAB genes 
were inserted additionally to yield plasmid pJNN.rhlAB.phzM+S. Thus in this work, we generated 
two newly engineered strains. The first strain is P. putida rhl-pca carrying the pBNT.14phz2 and 
pJNN.rhlAB plasmids, which was able to produce mono-rhamnolipid and PCA. The second strain 
was P. putida rhl-pyo, carrying the pBNT.14phz2 and pJNN.rhlAB.phzM+S plasmids, which was 
able to produce mono-rhamnolipid, PCA, and PYO. 
The introduction of the rhlAB operon, originating from P. aeruginosa PAO1, into P. putida 
KT2440 for the heterologous production of rhamnolipids has been previously successfully 
described. This non-pathogenic bacterium possesses both critical pathways for rhamnolipids 
precursor biosynthesis and grows well on glucose (Tiso et al., 2016; Wittgens et al., 2018; 
Wittgens et al., 2011). In this study, the rhlAB operon was inserted in the pJNN plasmid and was 
transformed into P. putida KT2440. This strain was additionally equipped with the pBNT.14phz2 
plasmid constructed for this thesis, enabling PCA production. This newly developed strain was 
termed P. putida rhl and was able to produce rhamnolipids and PCA in parallel. Additionally, a 
plasmid, in which the rhlAB operon was inserted in the pJNN.phzM+S plasmid (Schmitz et al., 
2015) was constructed and termed pJNN.rhlAB.phzM+S. In combination with the pBNT.14phz2 
plasmid, a strain called P. putida rhl-MS, which was able to produce PCA, PYO, and mono-
rhamnolipids was generated.  
Moreover, the growth behavior of eight picked colonies was compared on a multiplexed micro-
cultivation platform. The best performing P. putida rhl clone produced 730 mg/L mono-
rhamnolipids on LB media containing 10 g/L of glucose after 30 h of cultivation (Figure 18a). 
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Figure 18: Characterization of rhamnolipid producing P.putida. Rhamnolipid production of eight clones of (a) 
P. putida rhl (carrying pJNN.rhlAB plasmid) (b) P. putida rhl-MS (carrying pJNN.rhlAB.phzM+S plasmid) 
cultivated in the micro cultivation platform in LB media for 24 hours. 
 
Based on the HPLC quantification analysis, all of the four common mono-rhamnolipid congeners 
produced from P. aeruginosa were present, i.e., Rha-C10-10 (predominantly), Rha-C8-C10, Rha-C10-
C12, and Rha-C10-C12:1. As it was described by Behrens et al., in most of the cultivations that 
produced rhamnolipids, we found the same range of proportion from each congener (Behrens 
et al., 2016). These eight clones were characterized further in Delft minimum media containing 
10 g/L of glucose under the same cultivation condition, resulting in 360 ± 30 mg/L mono-
rhamnolipid production after 30 h of cultivation (Figure 19). The best P. putida rhl-MS clone was 
able to produce a maximum of 840 mg/L mono-rhamnolipid on LB media (Figure 18b) and 400 ± 
20 mg/L on Delft media, containing 10 g/L glucose (Figure 20). However, it was observed during 
the micro-cultivation experiment that some of the tested clones did not produce any mono-
rhamnolipid. A possible explanation could be plasmid loss during the cultivation.   
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Figure 19: Growth curve (a) vs. mono-rhamnolipid production (b) of eight clones of the P. putida rhl strain in the 
micro cultivation experiment (triplicates for each) in Delft media with 10 g/l glucose. For this cultivation 
platform, the “green value” is the output signal for biomass density. The star symbol indicates the 
selected clone to be characterized in the flask & BES experiment. 
 
Figure 20: Growth curve (a) vs. mono-rhamnolipid production (b) of eight clones of P. putida rhl-MS strain in the 
micro cultivation experiment (triplicates each) in Delft media with 10 g/L glucose. For this cultivation 
platform, the “green value” is the output signal for biomass density. The star symbol indicates the 
selected clone to be characterized in the flask & BES experiment.  
 
Figure 21: Growth curve (a) vs. mono-rhamnolipid & PCA production (b) of eight clones of the P. putida rhl-pca 
strain in the micro cultivation experiment (triplicates) in Delft media with 10 g/L glucose. For this 
cultivation platform, the “green value” is the output signal for biomass density. The star symbol indicates 
the selected clone to be characterized in the flask & BES experiment. 
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Figure 22: Growth curve (a) vs. mono-rhamnolipid, PCA & PYO production (b) of eight clones of the P. putida rhl-
pyo strain in the micro cultivation experiment (triplicates each) in Delft media with 10 g/L glucose. For 
this cultivation platform, the “green value” is the output signal for biomass density. The star symbol 
indicates the selected clone to be characterized in the flask & BES experiment. 
Several studies have been conducted to generate a recombinant host for rhamnolipid 
production. For example, Ochsner et al. established recombinant strains of P. fluorescens, 
P.putida, P. oleovorans, and E. coli to produce mono-rhamnolipid using glycerol as a substrate. 
Recombinant strains of P. fluorescens produced 250 mg/L, 600 mg/L of rhamnolipid from P. 
putida KT2440, but no mono-rhamnolipid was synthesized in E. coli and P. oleovorans (Ochsner 
et al., 1994). Another study conducted by Cabrera-Valladares et al. also reported the 
heterologous production of mono-rhamnolipids in E. coli W3110 that expressed the P. 
aeruginosa operons rhlAB and rmlBDAC (responsible for the dTDP-L-rhamnose synthesis 
pathway). By using glucose as a substrate, this strain produced 120 mg/L mono-rhamnolipid 
(Cabrera-Valladares et al., 2006). Notably, by utilizing soybean oil as substrate, Cha et al. 
reported on the expression of the rhlAB genes from P. aeruginosa in P. putida KCTC1067, 
resulting in 7.3 g/L mono-rhamnolipid (Cha et al., 2008). In general, P. aeruginosa produces 
rhamnolipid in highest rate on plant oils as a carbon source. However, it leads to unbeneficial 
and complicated procedures in the downstream processing of rhamnolipid production. More 
recently, heterologous rhamnolipid production from glucose with strain P. putida KT2440 
pVLT33_rhlAB conducted by Wittgens et al. produced 220 mg/L mono-rhamnolipid (Wittgens et 
al., 2011). Moreover, in work performed by Tiso et al. of the genetically optimized strain, 
P. putida pSynPro8 was generated, which was able to produce up to 3 g/L rhamnolipid (Tiso et 
al., 2016). In comparison with these other efforts for heterologous rhamnolipid production, the 
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here generated strains P. putida rhl and P. putida rhl-MS produced moderate amounts of mono-
rhamnolipid titer in aerobic cultivations on LB containing glucose. 
The best performing clone of the P. putida rhl as well as P. putida rhl-MS strain was sequentially 
further transformed with the pBNT.14phz2 plasmid expressing PCA, to generate the PCA- or 
PYO-expressing strains P. putida rhl-pca and P. putida rhl-pyo, respectively. The P. putida rhl-pca 
strain was characterized in a micro-cultivation under the same cultivation conditions, where it 
produced a maximum of 110 ± 0.52 mg/L mono-rhamnolipids and 54.38 ± 8.41 µg/mL PCA 
(Figure 21). P. putida rhl-pyo, on the other hand only produced a maximum of 50 ± 10 mg/L 
mono-rhamnolipids, 48.76 ± 0.24 µg/mL PCA, and 14.66 ± 0.35 µg/mL PYO (Figure 22). Hence, 
its performance concerning mono-rhamnolipid was rather low. It is likely that the introduction 
of both plasmids, each carrying different antibiotic, caused big stress to P. putida rhl-pyo strain. 
Notably, inserting the rhlAB genes in the pJNN plasmid containing phzM and phzS genes without 
the presence of the PCA producing plasmid (P. putida rhl-MS) showed enhanced rhamnolipid 
production compared to the strain without the phzM and phzS genes. Subsequently, the best 
performing P. putida rhl-pca and P. putida rhl-pyo clones, obtained from the micro-cultivation 
selection, were further characterized under aerobic conditions in shake flasks (Figure 23).  
As can be seen in Figure 23a, the best performing clone of P. putida rhl-pca was able to produce 
a maximum of 141 mg/L mono-rhamnolipids and 57.70 ± 18.41 µg/mL PCA after 48 hours of 
fully aerobic cultivation. Hence, the mono-rhamnolipid production of P. putida rhl-pca was 
higher than the production of the P. putida rhl strain, which only produced 110 ± 0.3 mg/L 
mono-rhamnolipids. By doubling the salicylate concentration during cultivation (2mM), mono-
rhamnolipid and PCA productions were further increased up to 152 ± 1,22 mg/L and 122 ± 12.49 
µg/mL, respectively. On the other hand, as it can be seen in Figure 23b, the P. putida rhl-pyo 
only produced mono-rhamnolipids at 50 ± 0.00 mg/L, PCA at 67.22 ± 7.80 µg/mL, and PYO at 
33.96 ± 2.8 µg/mL. By increasing the salicylate concentration, it was only possible to increase 
the PCA concentration up to 130.80 ± 16.83 µg/mL, yet it did not markedly increase the mono-
rhamnolipid concentration. Based on this result, we assumed that PYO production caused cell 
toxicity and negatively affected mono-rhamnolipid production. It is also supported by the lower 
OD600 observed from P. putida rhl-pyo compared to P. putida rhl-pca and P. putida rhl (Figure 
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24). This growth trend was also observed in P. putida 14.phz2+ strain (Chapter 3.1), which is also 
carrying two plasmids to produce PCA and PYO.  
 
 
Figure 23: Fully aerobic flasks cultivation (triplicates) for mono-rhamnolipid (m-rhamnol) and phenazine 
production (PCA and PYO). (a) P. putida rhl-pca and (b) P. putida rhl-pyo in Delft minimum media 
containing 10 g/L glucose. The sign ‘*’ followed after the strain name indicating two times of salicylate 
concentration given as plasmid inducer in the experiments.   
 
Figure 24: Fully aerobic flasks cultivation (triplicates) for growth observation (OD600). (a) P. putida rhl-pca and (b) 
P. putida rhl-pyo in Delft minimum media containing 10 g/L glucose. The letter ‘i’ followed after the 
strain name indicating two times of salicylate concentration given as plasmid inducer in the experiments 
57 
 
 
Figure 25: Anaerobic flasks experiment (triplicate) of P. putida SK1 with synthetic PCA and PYO added. Growth 
curve (a) Synthetic PCA & PYO concentration changes during the cultivation (b). 
 
In order to gain the understanding of phenazine effect to the mono-rhamnolipid-producing 
P. putida under oxygen-limited cultivation, a controlled study has been conducted by cultivating 
P. putida SK1 (genome integrated strain) in the anaerobic flask with synthetic phenazines added 
(Figure 25). Based on the growth observation, during the exponential phase, P. putida SK1 + 
PYOsynth culture grew faster compared to P. putida SK1 + PCAsynth culture and P. putida SK1 
without any phenazine culture. After 48 hours, P. putida SK1 + PYOsynth culture stopped growing 
and sustaining faster, due to the remaining oxygen in the headspace of serum bottle has been 
consumed faster as well. On the other hand, P. putida SK1 + PCAsynth and P. putida SK1 only 
cultures were still sustained the stationary phase up to 72 hours. None of the cultures produced 
mono-rhamnolipid. In these tests, the grown culture depends on how long the initial oxygen 
lasts to survive. The phenazines cannot be used for electron discharge since they are not 
regenerated at an anode.  
Regarding the phenazines analysis, the PCA was more sustained in the cultures compared to 
PYO, which was quickly gone after 24 hours. Since no electrode was present in these 
experiments, removal of the PYO from the solution through adsorption processes to the 
electrode is not possible. It showed that PCA was more potential to be employed as an electron 
shuttle in the BES reactor, combined with the rhamnolipid production. Therefore, from the 
strain evaluation in the aerobic and anaerobic flask cultivation, P. putida rhl-pca was chosen to 
be characterized further for bioelectrochemical production of rhamnolipids in the BES reactor.  
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3.2.3.2 Bioelectrochemical production of rhamnolipid in oxygen-limited BES 
3.2.3.2.1 Applying active aeration in BES 
Initially, as the controls experiments, the P. putida rhl (producing mono-rhamnolipid only) has 
been characterized in actively aerated BES reactors with and without electrode (Supplementary 
information Figure S10 and S11). Those experiments showed that there was no mono-
rhamnolipid produced in those reactors. Subsequently, the P. putida rhl-pca strain has also been 
characterized in actively aerated BES reactors without electrode (Supplementary information 
Figure S12), and it also showed the absence of mono-rhamnolipid production. From these 
control experiments, we expected the presence of a poised electrode in the oxygen-limited BES 
for P. putida rhl-pca cultivation would be beneficial as an alternative electron acceptor to 
support the rhamnolipid production.  
From the characterization of P. putida rhl-pca in aerobic shake flasks, we knew this strain was 
able to produce mono-rhamnolipid and PCA. And also, based on the work presented in the 
previous chapter, we knew that the highest PCA production and currents generation was 
obtained with P. putida carrying the phenazine genes from P. aeruginosa PA14 operon two 
under active aeration (AA). Therefore, we firstly tested the performance of P. putida rhl-pca in a 
polarized BES at 0.2 V vs. the reference electrode by applying active aeration at 30 ml/minute 
flow rate for 48 hours and then continued to passive aeration via opened vent filter (Figure 26).  
As it is shown in Figure 26a, the PCA production of the P. putida rhl-pca strain was 75.75 ± 13.76 
μg/mL, resulting in 10.65 ± 3.26 µA/cm2 of currents density. This PCA production was in the 
same range with the BES performance of the P. putida 14.phz2 strain (PCA producer only) 
presented in the previous chapter, i.e., there 80 μg/mL of PCA resulted in 11.77 µA/cm2 of 
currents generation. This result showed that pBNT.14phz2 plasmid stayed active expressing 
PCA. The glucose consumption was up to 89%, which was also in the same range compared to 
P. putida 14.phz2 strain (87%). Moreover, the P. putida rhl strain produced higher 2-
ketogluconate (predominantly) during the first three days of cultivation in BES reactor, which 
was up to 2.76 ± 0.51 mmol/L (compared to 0.63 mmol/L with P. putida 14.phz2, as described in 
Chapter 3.1). It is an interesting finding since 2-ketogluconate is also a potential compound for 
industrial application, such as in the pharmaceutical and cosmetics industries (Sun et al., 2018). 
59 
 
However, in this BES reactor set up, the P. putida rhl-pca strain did not produce any mono-
rhamnolipid until the end of the cultivation time (10 days).  
 
Figure 26: BES performance of P. putida rhl-pca at an applied potential of 0.2 V vs. RE. BES set up under (a) Active 
aeration, AA, at a flow rate of 30 ml/minute for 48 hours, then continued with passive headspace 
aeration (b) Active aeration plus, AA+, at a flow rate of 50 ml/minute continuously until the end of the 
experiment. The BES data are means from biological triplicates 
 
Therefore, another set up of BES reactor has been conducted by applying a higher airflow rate 
of 50 mL/minute continuously until the end of cultivation (AA+). The AA+ set up aimed to give 
more oxygen in the reactor, which serves an electron acceptor in the cellular catabolic reaction 
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to gain more energy for the cellular metabolism and with that to support the mono-rhamnolipid 
production in the BES culture. As can be seen in Figure 26b, the PCA production of AA+ reactors 
was increased by 16% compared to AA reactors, which resulted in a 30% increase of currents 
density. The glucose consumption was up to 93%, with the production of 2-ketogluconate as a 
side product, which was in the same range compared to AA reactors. There was still no mono-
rhamnolipid produced in those BES reactors set up. It is likely that in AA and AA+ reactors, most 
of the electrons likely go to oxygen respiration as the easiest and the most energy delivering 
route. Additionally, it showed that oxygen level in AA and AA+ reactors were not the limiting 
factors for bioelectrochemical production of mono-rhamnolipid in BES.  
 
3.2.3.2.2 Applying passive aeration BES 
Since it has been revealed that oxygen was not the main limiting factor for rhamnolipid 
production in AA, BES reactors were operated by only applying passive aeration of the 
headspace during the cultivation time. Figure 28 shows the performance of the P. putida rhl-pca 
strain in passively aerated BES (PA). Under stringent oxygen condition, this strain was able to 
produce 11.23 ± 0.78 μg/mL of PCA, which resulted in 8.07 ± 0.15 µA/cm2 current density. 
Although the glucose consumption (58.67 ± 2.08 %), as well as the metabolite production, was 
low, this strain surprisingly was able to produce the mono-rhamnolipid in low concentration, i.e. 
20.67 ± 0.15 mg/L at maximum. It is likely that in the absence of oxygen, the electron pressure 
becomes very high and activates the rhamnolipid production. The presence of mono-
rhamnolipid produced in the passively aerated BES reactors has been confirmed independently 
through TLC analysis for each of the reactors (Figure 27). We investigated three samples for the 
TLC analysis, each from a different reactor and cultivation time to scan the production range. 
The mono-rhamnolipids detected with the HPLC for reactor 1 during early cultivation (9 mg/L, 
day 1 of cultivation time) did not appear in the TLC plate. Probably the extraction method 
applied in this study was not able to extract this low concentration of mono-rhamnolipid. Based 
on the HPLC analysis, there were only two congeners of mono-rhamnolipid produced from this 
BES cultivation, i.e., Rha-C10-C10 and Rha-C10-C12, probably due to the low titer of rhamnolipid 
production. Additionally, the low rhamnolipid production in the passively aerated BES was in 
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accordance with the low cell density (OD600: ~1) observed during the cultivation of P. putida rhl-
pca.  
 
Figure 27: Thin-layer chromatography (TLC) analysis of the samples were taken from the second experiment BES 
reactors of P. putida rhl-pca strain under PA condition. Measured by HPLC quantitatively, r1: 9 mg/L 
(reactor 1, day 1), r2: 13 mg/L (reactor 2, day 3), and r3: 23 mg/L (reactor 3, day 7) of mono-rhamnolipid. 
 
The repetition of the experiment with the same setup and again in triplicates showed the same 
range of results for all of the parameters (Supplementary information Figure S14). It showed 
that the passive aeration set up is more suitable to be applied for bioelectrochemical production 
of rhamnolipid from P. putida rhl-pca, compared to actively aerated reactors. It is likely that 
under these most stringent oxygen levels, the need to get rid of electrons was higher and led 
the P. putida rhl-pca culture to store them in the form of rhamnolipids.  
To estimate the electrical energy retrieved from the glucose substrate in BES, we evaluated the 
coulombic efficiency from each BES set up, as shown in Figure 28d. The BES reactors of P. putida 
rhl-pca strain under PA condition had lower coulombic efficiencies (4.27 ± 1.73 %) compared to 
the AA (4.83 ± 0.68 %) and AA+ reactors (8.68 ± 3.83 %). However, this coulombic efficiency was 
in the same range as the passively aerated BES cultivation of P. putida 14.phz2, which produced 
PCA only, as described in Chapter 3.1.  
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Figure 28: BES performance of P. putida rhl-pca at an applied potential of 0.2 V vs. RE. (a-c) BES set up under 
passive aeration. The BES data are means from biological triplicate. (d) Coulombic efficiency comparison 
between the BES reactors of P. putida rhl (control), P. putida rhl-pca AA, AA+, and PA. 
 
3.2.3.3 Plasmid sustainability evaluation in the BES reactors  
 
Figure 29: Plasmid sustainability evaluation of P. putida rhl-pca strain BES reactors. (a) BES operation under PA 
conditions (triplicate), (b) BES operation under continuous active aeration, AA+ (single). K; indicating the 
percentage of colonies which grew on the LB+Kanamycin plate (carrying plasmid pBNT. 14phz2), G; 
indicating the percentage of colonies which grew on the LB+Gentamycin plate (carrying plasmid 
pJNN.rhlAB), and K+G; indicating the percentage of colonies which grew on the 
LB+Kanamycin+Gentamycin plate (carrying plasmid pBNT. 14phz2 and pJNN.rhlAB). 
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To verify if P. putida rhl-pca sustained to carry both of the plasmid expressing PCA and mono-
rhamnolipid during the cultivation in BES, a plasmid stability evaluation via positive selection 
plate counts has been conducted (del Solar et al., 1987). Figure 29a showed the plasmid 
evaluation of passively aerated BES reactors (triplicate from the second experiment) every 3 
days during the cultivation. It revealed that on day 3, the cells carrying plasmid pBNT.14phz2 
(selected through kanamycin resistance - K) were still above 80% and predominant, while the 
cultures carrying plasmid pJNN.rhlAB (selected through gentamycin resistance - G) were only 
28.37 ± 8.81 % and the cultures carrying both plasmids (K + G) were at ~70%. It might be the 
reason why the production of mono-rhamnolipid in the passively BES reactors was only 15% of 
the production under a fully aerobic condition in the flasks experiment. During the exponential 
growth (day 6), the percentage of the cultures in every selective antibiotic plate were increasing 
and sustained until stationary phase (day 9). Base on the proportion of the grown colonies from 
each selective plate, it can be seen that this method is not suitable to be applied for the plasmid 
sustainability determination during the BES cultivation. It is not explainable why the more 
colonies grew on the G+K plates than on the G only plates. Therefore, we could only use this 
method as tendency information for the likelihood of cells not carrying a plasmid during 
cultivation rather than for an exact quantification.  
In the meantime, a single BES reactor under AA+ aeration was also investigated for plasmid 
stability (Supplementary information Figure S13). As it can be seen in Figure 29b, the 
percentage of the cells in AA+ reactors for each selective antibiotic plate was lower compared to 
PA reactors. The cells carrying the pBNT.14phz2 plasmid was also predominant. Compared to 
the BES reactors under PA condition, the percentage of the cells which lost their plasmid was 
higher under AA+. The results showed that the density of P. putida rhl-pca cultures carrying the 
pJNN.rhlAB plasmid was below 50% during the cultivation in AA+ reactors. It might be one of 
the reasons for the absence of mono-rhamnolipid production in BES under AA/AA+ condition. 
However, the correlation between the oxygen level and the plasmid sustainability in the BES 
reactors AA+ is still unclear.  
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3.2.4  Conclusions 
In this study, we show that oxygen-limited biocatalysis of P. putida in BES has been established. 
We successfully generated a non-pathogenic strain, which was able to produce two compounds, 
i.e. phenazines and rhamnolipids, in which a complex quorum sensing network tightly controls 
their synthesis. For the first time, this study proved the concept that anodic bioproduction from 
glucose under strong oxygen limitation is possible by employing an engineered, obligately 
aerobic bacterium in BES. Under passively aerated conditions in a BES, survival through 
bioelectrochemical electron discharge to an anode was able to be coupled with the 
bioelectrochemical production of foam-free mono-rhamnolipids, by involving phenazines as 
redox mediator. This research finding opens the possibility to produce other types of glycolipid 
surfactant or other valuable amphiphilic compounds in BES reactors. The titer of mono-
rhamnolipids produced in the BES reactors could be increased by further improving the strain 
performance through genetic engineering, for example, by introducing strong promoters in the 
expression plasmid. By developing this approach with suitable BES operation, this could be a 
powerful strategy to produce valuable compounds and fuels from renewable resources in high 
carbon yield. 
 
 
 
 
 
4 Chapter 4 
 
 
General Discussion 
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4.1 State-of-the-art in rhamnolipid production for bio-detergents industry  
One of the industrial applications of rhamnolipids is their utilization as an additive compound 
for cleaning agents and detergents, as they are suitable natural emulsifiers and tension-active 
agents (Parry & S., 2013). The production of rhamnolipids in pilot-scale as an additive compound 
to cleaning products and detergents has already been conducted by several companies, such as 
Tee Gene Biotech (UK), Jeneil Biosurfactant Co. LLC (USA), and Henkel (Germany) (Sekhon 
Randhawa & Rahman, 2014). However, the cash flow for rhamnolipid scale-up production is still 
far too low to consider this biosurfactant as an alternative to synthetic surfactants, due to the 
high cost of raw materials and processing (Gong et al., 2015; Sekhon Randhawa & Rahman, 
2014). Several studies have been conducted to replace oil-based substrate with, for example, 
glucose, which resulted in a competitive titer and carbon yield (Tiso et al., 2016; Wittgens et al., 
2011). However, the existing strategy of the rhamnolipid production process has not been 
effectively applied yet. It is due to the complex metabolic regulation of the rhamnolipid 
production and strong foam formation in the fermenter during aerobic cultivation (Beuker et al., 
2016; Díaz De Rienzo et al., 2016; Muller et al., 2010). Rhamnolipid production with an efficient 
biocatalyst in an operating system that enables the conversion and conservation of renewable 
resources is very beneficial and therefore, a current focus in the process development. 
Furthermore, the foam-free rhamnolipid production will simplify the downstream processing 
while maintaining the production yield.    
In this study, I successfully generated a newly engineered strain of P. putida to synthesize 
phenazine redox mediators (P. putida 14.phz2), which was able to produce ten times higher PCA 
titers compared to the existing strain (Schmitz et al., 2015). Furthermore, I also successfully 
combined the mono-rhamnolipid synthesis with phenazine production by generating the  
P. putida rhl-pca strain, which has the genetical capacity to be employed as a biocatalyst for the 
bioelectrochemical production of rhamnolipids (Chapter 3.2). During the cultivation of P. putida 
rhl-pca in the passively aerated BES, we did not observe the foam formation within the 
bioreactor that is otherwise typical in non-BES rhamnolipid fermentation. At the end of the 
experiment, we applied vigorous aeration via a big sparger (500 L/minute), leading to the slight 
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formation of rainbowish bubbles within the reactor (Figure 31). However, the maximum titer of 
mono-rhamnolipids was quite low in both, the aerobic shake flask cultivations and the passively 
aerated, strongly oxygen-limited BES cultivations. We determined the keys factors to enhance 
bioelectrochemical foam-free mono-rhamnolipid production to be a further improvement of the 
recombinant rhamnolipid productivity and optimization of the bioelectrochemical production. 
Additionally, this study opens the path to the production of other types of glycolipids surfactant 
with oxygen-limited BES. 
 
 
Figure 30: Scheme of bioelectrochemical production of mono-rhamnolipid P. putida rhl-pca using glucose as 
substrate, facilitated by PCA as an electron shuttle in passively aerated-BES at an applied potential of 
0.2V vs. RE 
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Figure 31: Bubble formation in the passively aerated BES (reactor 1), after being sparged with vigorous aeration at 
a flow rate 500 mL/minute (at the end of the experiment, day 10). 
 
4.2 Evaluation of the productivity of the recombinant rhamnolipid strain  
In our initial study (Chapter 3.2), we attempted to obtain a stable recombinant host for 
rhamnolipid production by combining P. putida SK1 (contains genome integration of rhlA 
and rhlB) (Wittgens et al., 2011) with our new pBNT.O1phz2 plasmid. The new transformed 
strain produced no mono-rhamnolipids, although the PCA production was 4-times higher 
than in the P. putida O1.phz2 strain (expressing PCA only), i.e., 140 ± 30 µg/mL (Kastenholz, 
2017). Likely, the introduction of the phenazine-expressing plasmid in the P. putida SK1 
strain repressed rhlAB genes expression. In this strain, the operon is inserted into the 
genomic 16S rDNA sequence.  
Nonetheless, the production of both PCA and mono-rhamnolipid was successfully coupled in 
the plasmid-based P. putida rhl-pca strain. The ability of this strain to produce both of the 
compounds enables the bioelectrochemical production of mono-rhamnolipids as model 
compounds. Although they might be genetically-less stable, the plasmid-based strains 
generated in this study were a better approach compared to the initial genome integrated 
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strategy. P. putida rhl-pca was able to cope with two introduced plasmids, which contain 
two different antibiotic resistance gene cassettes (kanamycin and gentamycin). However, 
the strains generated in this study produced lower maximum titers of rhamnolipids in both 
anaerobic flasks and passively aerated BES cultivations, when compared to other 
recombinant rhamnolipid producers (Table 7). For comparison, P. putida KT2440 pSynPro8 is 
a good example of recombinant host improvement. The new synthetic constitutive SynPro 
promoter and the rhlAB genes inserted in the pBBR1MSC-3 vector backbone proved to 
increase the rhamnolipid titer to up to 3 g/L in LB aerobic shake flasks (Tiso et al., 2016). In 
the future, an optimization of the bioelectrochemical rhamnolipid production could be 
achieved by further engineering the strain with this more advanced plasmid system and 
synthetic constitutive promoters.  
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Table 7: Recombinant rhamnolipid producer strains in this study compared to other strains 
Organism Medium Substrate 
 
Substrate 
conc. (g/L) 
Maximum 
titer (g/L) 
Carbon yield 
(Cmolrhamnolipid/ 
Cmolsubstrate) 
Growth 
condition 
Reference 
P. aeruginosa 
PAO1 (wt) 
Mineral 
Salts (MS) 
Sunflower 
oil 
250 39 0,07 aerobic 
fermenter 
(Muller et 
al., 2010) 
P. putida 
KCTC 1067 
MS Soybean 
oil 
20 7,3 0,17 aerobic 
flask 
(Cha et al., 
2008) 
P. putida 
KT42C1 
pVLT31_rhlAB 
LB Glucose 10 1,5 0,23 aerobic, 
flask 
(Wittgens 
et al., 
2011) 
P. putida 
KT2440 
pSynPro8 
LB Glucose 10 3 0,40 aerobic, 
flask 
(Tiso et 
al., 2016) 
P. putida SK1 LB Glucose 10 1,25 0,19 aerobic,  
shaking 
flask 
(Kruth, 
2017) 
P. putida rhl LB Glucose 10 0,73 0,11 aerobic, 
flask 
this study 
P. putida rhl Delft Glucose 10 0,36 0,06 aerobic, 
multiplex 
well 
this study 
P. putida rhl-
pca 
Delft Glucose 10 0,11 0,02 aerobic, 
multiplex 
well 
this study 
P. putida rhl-
pca 
Delft Glucose 10 0,141 0,02 aerobic, 
flask 
this study 
P. putida rhl-
pca 
Delft Glucose 10 0,152 0,02 aerobic 
flask, 2x 
induction 
this study 
P. putida rhl-
MS 
LB Glucose 10 0,84 0,13 aerobic, 
flask 
this study 
P. putida rhl-
MS 
Delft Glucose 10 0,4 0,06 aerobic, 
multiplex 
well 
this study 
P. putida rhl-
pyo 
LB Glucose 10 0,05 <0,01 aerobic, 
multiplex 
well 
this study 
P. putida rhl-
pyo 
Delft Glucose 10 0,05 <0,01 aerobic, 
flask 
this study 
P. putida rhl-
pyo 
Delft Glucose 10 0,05 <0,01 aerobic, 
flask, 2x 
induction 
this study 
P. putida rhl-
pca 
Delft Glucose 5 0,02 0,22 oxygen-
limited 
BES (PA) 
this study 
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4.3 Bioelectrochemical production optimization  
The process operation of the BES can be further explored and optimized to enhance 
bioelectrochemical productions. For example, by changing the size or shape of the working 
electrode (WE), we expect to get more current to support the bioelectrochemical production. In 
our study, we attempted to improve the rhamnolipid production of P. putida rhl-pca in the BES 
reactor by increasing the surface area of the WE to provide a larger surface for 
bioelectrochemical interaction. Therefore, a woven carbon cloth (400 cm2 surface area) was 
used in duplicate actively aerated BES (AA). However, this approach did not yield the proposed 
results (Figure 32). The culture stopped growing on day 4, no mono-rhamnolipids were 
produced, and the current generation was lower than in the cultivation of P. putida rhl-pca 
using the solid carbon comb electrode under the same set up (AA). It shows that in the case of a 
single chamber BES reactor, increasing the surface area of the WE does not effectively work to 
increase the current generation with this strain.  
 
Figure 32: Comparison of BES performance of P. putida rhl-pca at an applied potential of 0.2 V vs. RE using 
carbon comb and carbon cloth as WE. (a) BES set up with a carbon comb electrode (400 cm²) under 
active aeration, AA, at a flow rate of 30 ml/minute for 48 hours, then continued with passive headspace 
aeration. The BES data are means from biological triplicates, taken from Chapter 3.2 (b) BES production 
of P. putida rhl-pca (biological duplicate) using a woven carbon cloth (400 cm
2
) as working electrode and 
the same aeration conditions as (a). 
 
The ability of the P. putida rhl-pca strain to produce a redox mediator and the target product 
enables the bioelectrochemical production of mono-rhamnolipids as model compounds, which 
in the future can be developed further towards productivity optimization. The bioproduction 
under anaerobic condition will potentially be an economic advantage, due to the reduced 
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substrate loss in the form of CO2 during anaerobic metabolism and the resulting higher carbon 
yield (Tashiro et al., 2015). The carbon yield of P. putida rhl-pca in passively aerated BES was 
0.22 Cmol rhamnolipid/Cmol substrate, which is higher than the best production with this strain under 
aerobic cultivation (highlighted blue colour in Table 7) and comparable to strains engineered in 
other studies (Beuker et al., 2016; Sekhon Randhawa & Rahman, 2014).   
In this study, we showed the production of rhamnolipid by providing an extracellular electron 
sink to P. putida rhl-pca in the form of electrodes and redox mediators in passively aerated BES. 
However, a more detailed study to understand and enhance the respiration tendency through 
phenazines in P. putida rhl-pca is necessary to reduce the cellular metabolic constraint that is 
hindering utilization of the substrate in stringent oxygen-limited BES. In chapter 3.2, it is shown 
that the coulombic efficiency of P. putida rhl-pca was only at 4.27 ± 1.73 % in passively aerated 
BES. It means that at this point only ~4.27 % of the electrons provided by the substrate were 
shuttled (respired) via the phenazines to the anode, while the rest of the electrons were passed 
to oxygen as the main electron acceptor. Thus, the electron discharge efficiency of P. putida to 
the anode is very low. A central question for any rational improvement of this anodic electron 
discharge process will be the clarification of the electron transfer pathways from the cellular 
metabolism to the phenazines as electron shuttles. Therefore, a study to gain an understanding 
of why P. putida KT2440 could not discharge more electrons via the phenazine needs to be 
conducted. This already ongoing investigation deals with the following questions: (i) how are 
the phenazine currently linked within the P. putida KT2440 metabolism, and (ii) how should they 
ideally be linked in to trigger a more efficient phenazine based respiration. Therefore, a more in-
depth flux balance analysis related to the NADP+/NADPH ratio in oxygen-limited BES is needed.  
Furthermore, when considering energy generation, a deeper flux balance analysis can help to 
predict the rate of ATP synthesis through ATP synthase, which is depending on the available 
proton gradient (Lai et al., 2016). As it has been reported by Glasser et al. (Glasser et al., 2014) 
that phenazines play a role in anaerobic survival mechanism, the ATP synthesis in P. putida rhl-
pca might be changed into a different rate. Understanding the total energy involved in 
rhamnolipid formation (or any other valuable product) will support the optimization of anodic 
oxidation from the carbon substrate in passively aerated BES. This investigation will be very 
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beneficial to sustain more active biocatalysis, as well as the viability of the cells in the strongly 
oxygen-limited BES.      
4.4 Expanding the concept to the heterologous production of other types of 
glycolipid surfactants 
As introduced in Chapter 1, glycolipid surfactants are highly attractive compounds for industrial 
application. Therefore, the bioelectrochemical production of rhamnolipids from P. putida rhl-
pca in passively aerated BES is an essential initial study. The findings of this study showed that it 
is possible to electrochemically produce foam-free glycolipid surfactants, at a stringent level of 
oxygen, by employing phenazines as redox shuttle compound. 
Several glycolipid surfactants have been intensively studied from their native producer. For 
example, the gene operon involved in the synthesis of mannosylerythritol lipids originating from 
Pseudozyma (Morita et al., 2014; Saika et al., 2016) and Ustilago maydis (Hewald et al., 2006) 
has been fully characterized. A study of mannosylerythritol lipids production in anaerobic 
fermenter showed the same problem as in the production of rhamnolipids, i.e., the formation of 
excessive foam and therefore required a complicated method in the downstream processing 
(Rau et al., 2005). Additionally, another type of potential glycolipid surfactant, so-called 
sophorolipids are also well-studied. The functional gene responsible for sophorolipids synthesis 
in Candida bambicola (Solaiman et al., 2014) and Starmerella bambicola (Geys et al., 2018) has 
been characterized. Although sophorolipids are considered low-foam forming biosurfactant, 
compared to mannosylerythritol lipids (Hirata et al., 2009), my work could be useful to design 
new bioprocess strategies for the heterologous production of mannosylerythritol lipids as well 
as sophorolipids. The heterologous production of these compounds could be tailored further 
with our phenazine plasmid to develop a bioelectrochemical production in BES, with high 
carbon yield and purity.  
 
 
 
 
 
 
 
5 Chapter 5 
 
 
Concluding remarks and Outlook 
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5.1 Concluding remarks 
In this study, we showed that the heterologous phenazine production in P. putida could be 
tuned and enhanced by exploring the natural gene variability of the native hosts. Following the 
work from Schmitz et al., we successfully expressed the other three phenazine synthesis gene 
origins originating from operon 2 of P. aeruginosa PAO1, operon 1 of P. aeruginosa PA14, and 
operon two of P. aeruginosa PA14. Notably, the phenazine-1-carboxylic acid synthesis operon 
two from P. aeruginosa PA14 was found to be the most active in the heterologous phenazine 
production in P. putida, both in the aerobic shake flask and oxygen-limited BES cultivation. This 
gene origin was chosen to be tailored further with rhamnolipid production.  
By applying a plasmid-based genetic engineering strategy, new strains of P. putida was 
successfully generated and produced mono-rhamnolipid, i.e., P. putida rhl and P. putida rhl-MS. 
Hereinafter, the heterologous mono-rhamnolipid production in P. putida has been successfully 
coupled with the phenazine production to create strain P. putida rhl-pca (produces PCA and 
mono-rhamnolipid) and P. putida rhl-pyo (produces PCA, PYO, and mono-rhamnolipid). Based 
on the maximum titer of mono-rhamnolipid produced in aerobic shake flasks, P. putida rhl-pca 
was chosen for bioelectrochemical production.  
The oxygen-limited cultivations with redox balancing at an anode via phenazines can be coupled 
to rhamnolipid biosynthesis by employing plasmid-based genetic engineered P. putida. The 
oxygen-limitation level applied in the BES reactor was evaluated for bioelectrochemical 
production of rhamnolipid. The result of our study showed that passive headspace aeration of 
BES was suitable to be applied for bioelectrochemical production of foam-free rhamnolipid from 
P. putida rhl-pca. The increased carbon yield obtained from P. putida rhl-pca in passively 
aerated BES showed a potential economic advantage for the glycolipid surfactant 
bioproduction. However, further strain improvement for higher rhamnolipid titer production, 
optimizing the BES reactor set-up and investigating the main metabolic aspect to increase the 
tendency to respire with phenazine as an alternative electrons acceptor, are necessary for the 
bioelectrochemical production. Overall, this work is an initial study showing that the 
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bioelectrochemical production of foam-free glycolipid surfactants by employing phenazines as 
electron shuttle is possible.   
5.2 Outlook 
5.2.1 Rhamnolipid recombinant host improvement 
Based on the maximum rhamnolipid titer produced from P. putida rhl-pca, the 
bioelectrochemical production of rhamnolipid was still far away from any industrial application. 
A strain improvement strategy can be applied to obtain a higher titer of the rhamnolipid 
production, e.g. by constructing a new rhamnolipid producer plasmid containing a synthetic 
promoter designed to enhance the rhamnolipid synthesis enzyme expression and precursor 
availability (Beuker et al., 2016) and also using constitutive promoter to omit the dependency of 
the plasmid inducer (Tiso et al., 2016). Another molecular approach is improving the copy 
number of genes in the genome-integrated strain to express more of the rhamnolipid enzymes. 
It could be achieved by applying the chromosomal integration of gene(s) with multiple copies 
(CIGC) method, using the flippase from the yeast 2-mm plasmid (Gu et al., 2015). Hence, a 
better bioproduction strain chassis could be obtained to be combined with the phenazine 
plasmid.   
5.2.2 BES reactor operation  
Another approach proposed to be implemented for the optimization of bioelectrochemical 
production is the cultivation of P. putida rhl-pca in an electro-bioreactor. Basically, this is better 
integration of the electrochemical setup with classical, highly monitored bioprocess technology. 
It has been reported by Rosa et al., who developed an upgrade kit (a bioreactor lid equipped 
with electrochemical control) integrated with the commercial fermenter system, which enables 
full process monitoring. In the case study of Shewanella oneidensis MR-1, they proved that this 
system could be applied to control, monitor, and scale microbial bioelectrochemical production 
of acetate and lactate, with a much better resolution of the experimental data provided (Rosa et 
al., 2017). Another study of this research group conducted by Gimkiewicz et al. has applied this 
system to show that Gluconobacter oxydans is not suitable to be employed in microbial 
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electrochemical technologies, due to the absence of an immediate link between the microbial 
metabolism and electric current generation (Gimkiewicz et al., 2016). 
Moreover, a case study of Clostridium kluyveri with the synthetic electron mediator added using 
the same system by Koch et al., showed that this type of bioreactor was applied to reveal that 
C. kluyveri is not able to directly interact with electrodes (Koch et al., 2017). These case studies 
showed the prospect of this advanced bioreactor system to be applied for bioelectrochemical 
production of valuable compounds from a wide range of electroactive bacterium species. 
Especially in the P. putida rhl-pca strain, the ability to endogenously produce phenazines as the 
electron mediator will be an advantage. 
Furthermore, the bioelectrochemical production of rhamnolipid using this type of reactor will 
be interesting to be investigated, since this system is equipped with an integrated monitored 
and controlled system for bioproduction (pH, dissolved oxygen, foam). Therefore, the 
experimental variables for rhamnolipid production can be more in-depth studies, such as 
aeration level, inoculation, and pH. Collaboration contract negotiations and translation of the 
technology to our laboratory is almost completed, and bioproduction with the new phenazine 
and rhamnolipid producing strain in these electro-bioreactors will be conducted soon.  
5.2.3 Integrated redox and flux balance analysis 
Based on the finding of this study, the optimization of the bioelectrochemical production using 
phenazine as the electron shuttle in a passively aerated BES required a comprehensive 
understanding of the cellular electrons redox balance within P. putida. Especially, the molecular 
function of phenazines as an electron shuttle to carry electrons to the anode under passively 
aerated BES and the connection to an energy conservation process needs to be elucidated. This 
comprehensive physiological study can be integrated with flux balance analysis (based on 
pathway stoichiometry and product formation rates) (Lai et al., 2016) to discover an effective 
and efficient metabolic engineering strategy for biocatalysis of P. putida in an oxygen-limited 
BES.    
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7 Appendix 
A.1 Supplementary information Chapter 3.1 
A Constructed Plasmids expressing phenazine genes used in Chapter 3.1  
 
Figure S1: Vectors expressing phenazine genes used in chapter 3.1; (a) pBNT.O1phz2, expressing phzA-G operon 2 
from P. aeruginosa PAO1 (PA1899-PA1905); (b) pBNT.14phz1, expressing phzA-G operon 1 from 
P. aeruginosa PA14 (PA14_09410-PA14_09480); (c) pBNT.14phz2, expressing phzA-G operon 2 from 
P. aeruginosa PA14 (PA14_39880-PA14_39970). The schemes represent all of the important elements, 
including the phenazine genes (phzA-G), the Kanamycin resistance cassette (kmR), the terminator (Tn-1), 
the origin of replication (ori/IHF for Pseudomonas), and the salycilate-induced promoter (pnagAa/nagR). 
B In silico phenazine gene origin analysis 
Data S1 - Protein alignments: 
According to Clustal documentation (http://www.clustal.org/omega/), the meaning of the 
symbols in the output is the following (simplified): 
 Asterisk: Conserved position 
 Colon: Strongly similar properties (only for amino acids) 
 Period: Weakly similar properties (only for amino acids) 
The following UNIX command has been used with different inputs to perform all the alignments: 
clustalo -i input_sequences.fasta -o output_alignment --outfmt clu 
--resno --force --guidetree-out output_tree 
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Alignment for PhzA: 
 
CLUSTAL O(1.2.4) multiple sequence alignment 
 
PAO1_1      MNGQRYRETPLDIERLRRLNRATVERYMAMKGAERLQRHSLFVEDGCAGNWTTESGEPLV 60 
PAO1_2      MREYQRLKGFTDNLELRRRNRATVEHYMRMKGAERLQRHSLFVEDGCAGNWTTESGEPLV 60 
PA14_1      MNGQRYRETPLDIERLRRLNRATVERYMAMKGAERLQRHSLFVEDGCAGNWTTESGEPLV 60 
PA14_2      MREYQRLKGFTDNLELRRRNRATVEHYMRMKGAERLQRHSLFVEDGCAGNWTTESGEPLV 60 
            *.  :  :   *  .*** ******:** ******************************* 
             
PAO1_1      FRGHESLRRLAEWLERCFPDWEWHNVRIFETEDPNHFWVECDGRGKALVPGYPQGYCENH 120 
PAO1_2      FRGHESLRRLAEWLERCFPDWEWHNVRIFETEDPNHFWVECDGRGKALVPGYPQGYCENH 120 
PA14_1      FRGHESLRRLAEWLERCFPDWEWRNVRIFETEDPNHFWVECDGRGKALVPGYPQGYCENH 120 
PA14_2      FRGHESLRRLAEWLERCFPDWEWHNVRIFETEDPNHLWVECDGRGKALVPGYPQGYCENH 120 
            ***********************:************:*********************** 
             
PAO1_1      YIHSFELENGRIKRNREFMNPIQKLRALGIAVPQIKRDGIPT 162 
PAO1_2      YIHSFELENGRIKRNREFMNPMQKLRALGIAVPQIKRDGIPT 162 
PA14_1      YIHSFELENGRIKRNREFMNPMQKLRALGIAVPQIKRDGIPT 162 
PA14_2      YIHSFELENGRIKRNREFMNPMQKLRALGIAVPQIKRDGIPT 162 
            *********************:******************** 
 
Alignment for PhzB: 
 
CLUSTAL O(1.2.4) multiple sequence alignment 
 
PAO1_1      MPDTTNPIGFTDANELREKNRATVEKYMNTKGQDRLRRHELFVEDGCGGLWTTDTGSPIV 60 
PAO1_2      MLDNAIPQGFEDAVELRRKNRETVVKYMNTKGQDRLRRHELFVEDGCGGLWTTDTGSPIV 60 
PA14_1      MPDTTNPIGFTDANELREKNRATVEKYMNTKGQDRLRRHELFVEDGCGGLWTTDTGSPIV 60 
PA14_2      MLDNAIPQGFEDAVELRRKNRETVVKYMNTKGQDRLRRHELFVEDGCGGLWTTDTGSPIV 60 
            * *.: * ** ** ***.*** ** *********************************** 
 
PAO1_1      IRGKDKLAEHAVWSLKCFPDWEWYNINIFGTDDPNHFWVECDGHGKILFPGYPEGYYENH 120 
PAO1_2      IRGKDKLAEHAVWSLKCFPDWEWYNIKVFETDDPNHFWVECDGHGKILFPGYPEGYYENH 120 
PA14_1      IRGKDKLAEHAVWSLKCFPDWEWYNINIFGTDDPNHFWVECDGHGKILFPGYPEGYYENH 120 
PA14_2      IRGKDKLAEHAVWSLKCFPDWEWYNIKVFETDDPNHFWVECDGHGKILFPGYPEGYYENH 120 
            **************************::* ****************************** 
 
PAO1_1      FLHSFELEDGKIKRNREFMNVFQQLRALSIPVPQIKREGIPT 162 
PAO1_2      FLHSFELDDGKIKRNREFMNVFQQLRALSIPVPQIKREGIPT 162 
PA14_1      FLHSFELEDGKIKRNREFMNVFQQLRALSIPVPEIKREGIPT 162 
PA14_2      FLHSFELDDGKIKRNREFMNVFQQLRALSIPVPQIKREGIPT 162 
            *******:*************************:******** 
 
Alignment for PhzC: 
 
CLUSTAL O(1.2.4) multiple sequence alignment 
 
PAO1_1      MDDLLQRVRRCEALQQPEWGDPSRLRDVQAYLRGSPALIRAGDILALRATLARVARGEAL 60 
PAO1_2      MDDLLQRVRRCEALQQPEWGDPSRLRDVQAYLRGSPALIRAGDILALRATLARVARGEAL 60 
PA14_1      MDDLLQRVRRCEALQQPEWGDPSRLRDVQAYLRGSPALIRAGDILALRATLARVARGEAL 60 
PA14_2      MDDLLQRVRRCEALQQPEWGDPSRLRDVQAYLRGSPALIRAGDILALRATLARVARGEAL 60 
            ************************************************************ 
  
A3 
 
PAO1_1      VVQCGDCAEDMDDHHAENVARKAAVLELLAGALRLAGRRPVIRVGRIAGQYAKPRSKPHE 120 
PAO1_2      VVQCGDCAEDMDDHHAENVARKAAVLELLAGALRLAGRRPVIRVGRIAGQYAKPRSKPHE 120 
PA14_1      VVQCGDCAEDMDDHHAENVARKAAVLELLAGALRLAGRRPVIRVGRIAGQYAKPRSKPHE 120 
PA14_2      VVQCGDCAEDMDDHHAENVARKAAVLELLAGALRLAGRRPVIRVGRIAGQYAKPRSKPHE 120 
            ************************************************************ 
 
PAO1_1      QVGEQTLPVYRGDMVNGREAHAEQRRADPQRILKGYAAARNIMRHLGWDAASGQEANASP 180 
PAO1_2      QVGEQTLPVYRGDMVNGREAHAEQRRADPQRILKGYAAARNIMRHLGWDAASGQEANASP 180 
PA14_1      QVGEQTLPVYRGDMVNGREAHAEQRRADPQRILKGYAAARNIMRHLGWDAASGQEANASP 180 
PA14_2      QVGEQTLPVYRGDMVNGREAHAEQRRADPQRILKGYAAARNIMRHLGWDAASGQEANASP 180 
            ************************************************************ 
 
PAO1_1      VWTSHEMLLLDYELSMLREDEQRRVYLGSTHWPWIGERTRQVDGAHVALLAEVLNPVACK 240 
PAO1_2      VWTSHEMLLLDYELSMLREDEQRRVYLGSTHWPWIGERTRQVDGAHVALLAEVLNPVACK 240 
PA14_1      VWTSHEMLLLDYELSMLREDEQRRVYLGSTHWPWIGERTRQVDGAHVALLAEVLNPVACK 240 
PA14_2      VWTSHEMLLLDYELSMLREDEQRRVYLGSTHWPWIGERTRQVDGAHVALLAEVLNPVACK 240 
            ************************************************************ 
 
PAO1_1      VGPEIGRDQLLALCERLDPRREPGRLTLIARMGAQKVGERLPPLVEAVRAAGHPVIWLSD 300 
PAO1_2      VGPEIGRDQLLALCERLDPRREPGRLTLIARMGAQKVGERLPPLVEAVRAAGHPVIWLSD 300 
PA14_1      VGPEIGRDQLLALCERLDPRREPGRLTLIARMGAQKVGERLPPLVEAVRAAGHPVIWLSD 300 
PA14_2      VGPEIGRDQLLALCERLDPRREPGRLTLIARMGAQKVGERLPPLVEAVRAAGHPVIWLSD 300 
            ************************************************************ 
PAO1_1      PMHGNTIVAPCGNKTRLVRSIAEEVAAFRLAVSGSGGVAAGLHLETTPDDVTECVADSSG 360 
PAO1_2      PMHGNTIVAPCGNKTRLVRSIAEEVAAFRLAVSGSGGVAAGLHLETTPDDVTECVADSSG 360 
PA14_1      PMHGNTIVAPCGNKTRLVRSIAEEVAAFRLAVSGSGGVAAGLHLETTPDDVTECVADSSG 360 
PA14_2      PMHGNTIVAPCGNKTRLVRSIAEEVAAFRLAVSGSGGVAAGLHLETTPDDVTECVADSSG 360 
            ************************************************************ 
 
PAO1_1      LHQVSRHYTSLCDPRLNPWQALSAVMAWSGAEAIPSATFPLETVA 405 
PAO1_2      LHQVSRHYTSLCDPRLNPWQALSAVMAWSGAEAIPSATFPLETVA 405 
PA14_1      LHQVGRHYTSLCDPRLNPWQALSAVMAWAGAEATPSATFPLETVA 405 
PA14_2      LHQVSRHYTSLCDPRLNPWQALSAVMAWAGAEAIPSATFPLETVA 405 
            ****.***********************:**** *********** 
 
Alignment for PhzD: 
 
CLUSTAL O(1.2.4) multiple sequence alignment 
 
PAO1_1      MSGIPEITAYPLPTAQQLPANLARWSLEPRRAVLLVHDMQRYFLRPLPESLRAGLVANAA 60 
PAO1_2      MSGIPEITAYPLPTAQQLPANLARWSLEPRRAVLLVHDMQRYFLRPLPESLRAGLVANAA 60 
PA14_1      MSGIPEITAYPLPTAQQLPANLARWSLEPRRAVLLVHDMQRYFLRPLPESLRAGLVANAA 60 
PA14_2      MSGIPEITAYPLPTAQQLPANLARWSLKPRRAVLLVHDMQRYFLRPLPESLRAGLVANAA 60 
            ***************************:******************************** 
 
PAO1_1      RLRRWCVEQGVQIAYTAQPGSMTEEQRGLLKDFWGPGRASPADREVVEELAPGPDDWLL 120 
PAO1_2      RLRRWCVEQGVQIAYTAQPGSMTEEQRGLLKDFWGPGRASPADREVVEELAPGPDDWLL 120 
PA14_1      RLRRWCVEQGVQIAYTAQPGSMTEEQRGLLKDFWGPGRASPADREVVEELAPGPDDWLL 120 
PA14_2      RLRRWCVEQGVQIAYTAQPGSMTEEQRGLLKDFWGPGRASPADREVVEELAPGPDDWLL 120 
            ************************************************************ 
 
PAO1_1      TKWRYSAFFHSDLLQRMRAAGRDQLVLCGVYAHVGVLISTVDAYSNDIQPFLVADAIADF 180 
PAO1_2      TKWRYSAFFHSDLLQRMRAAGRDQLVLCGVYAHVGVLISTVDAYSNDIQPFLVADAIADF 180 
PA14_1      TKWRYSAFFHSDLLQRMRAAGRDQLVLCGVYAHVGVLISTVDAYSNDIQPFLVADAIADF 180 
PA14_2      TKWRYSAFFHSDLLQRMRAAGRDQLVLCGVYAHVGVLISTVDAYSNDIQPFLVADAIADF 180 
            ************************************************************ 
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PAO1_1      SEAHHRMALEYAASRCAMVVTTDEVLE 207 
PAO1_2      SEAHHRMALEYAASRCAMVVTTDEVLE 207 
PA14_1      SEAHHRMALEYAASRCAMVVTTDEVLE 207 
PA14_2      SEAHHRMALEYAASRCAMVVTTDEVLE 207 
            *************************** 
 
Alignment for PhzE: 
 
CLUSTAL O(1.2.4) multiple sequence alignment 
 
PAO1_1      MNALPTSLLQRLLERPAPFALLYRPESNGPGLLDVIRGEALELHGLADLPLDEPGPGLPR 60 
PAO1_2      MNALPTSLLQRLLERPAPFALLYRPESNGPGLLDVIRGEALELHGLADLPLDEPGPGLPR 60 
PA14_1      MNALPTSLLQRLLERPAPFALLYRPESNGPGLLDVIRGETLELHGLADLPLDEPGPGLPR 60 
PA14_2      MNALPTSLLQRLLERPAPFALLYRPESNGPGLLDVIRGETLELHGLADLPLDEPGPGLPR 60 
            ***************************************:******************** 
 
PAO1_1      HDLLALIPYRQIAERGFEALDDGTPLLALKVLEQELLPLEQALALLPNQALELSEEGFDL 120 
PAO1_2      HDLLALIPYRQIAERGFEALDDGTPLLALKVLEQELLPLEQALALLPNQALELSEEGFDL 120 
PA14_1      HDLLALIPYRQIAERGFEALDDGTPLLALKVLEQELLPLEQALALLPNQALELSEEAFDL 120 
PA14_2      HDLLALIPYRQIAERGFEALDDGTPLLALKVLEQELLPLEQALALLPNQALELSEEAFDL 120 
            ********************************************************.*** 
 
PAO1_1      DDEAYAEVVGRVIADEIGRGEGANFVIKRRFQARIDGYATASALSFFRQLLLREKGAYWT 180 
PAO1_2      DDEAYAEVVGRVIADEIGRGEGANFVIKRRFQARIDGYATASALSFFRQLLLREKGAYWT 180 
PA14_1      DDEAYAEVVGRVIADEIGRGEGANFVIKRRFQARIDGYATASALSFFRQLLLREKGAYWT 180 
PA14_2      DDEAYAEVVGRVIADEIGRGEGANFVIKRRFQARIDGYATASALSFFRQLLLREKGAYWT 180 
            ************************************************************ 
 
PAO1_1      FIVHTGERTLVGASPERHISVRDGLAVMNPISGTYRYPPAGPNLAEVMEFLDNRKEADEL 240 
PAO1_2      FIVHTGERTLVGASPERHISVRDGLAVMNPISGTYRYPPAGPNLAEVMEFLDNRKEADEL 240 
PA14_1      FIVHTGERTLVGASPERHISVRDGLAVMNPISGTYRYPPAGPNLAEVMEFLDNRKEADEL 240 
PA14_2      FIVHTGERTLVGASPERHISVRDGLAVMNPISGTYRYPPAGPNLAEVMEFFDNRKEADEL 240 
            **************************************************:********* 
 
PAO1_1      YMVVDEELKMARICEDGGRVLGPYLKEMAHLAHTEYFIEGQTSRDVREVLRETLFAPTV 300 
PAO1_2      YMVVDEELKMARICEDGGRVLGPYLKEMAHLAHTEYFIEGQTSRDVREVLRETLFAPTV 300 
PA14_1      YMVVDEELKMARICEDGGRVLGPYLKEMAHLAHTEYFIEGQTSRDVREVLRETLFAPTV 300 
PA14_2      YMVVDEELKMARICEDGGRVLGPYIKEMAHLAHTEYFIEGQTSRDVREVLRETLFAPTV 300 
            *************************:********************************** 
 
PAO1_1      TGSPLESACRVIRRYEPQGRGYYSGVAALIGGDGQGGRTLDSAILIRTAEIEGDGRLRIG 360 
PAO1_2      TGSPLESACRVIRRYEPQGRGYYSGVAALIGGDGQGGRTLDSAILIRTAEIEGDGRLRIG 360 
PA14_1      TGSPLESACRVIRRYEPQGRGYYSGVAALIGGDGQGGRTLDSAILIRTAEIESDGRLRIG 360 
PA14_2      TGSPLESACRVIRRYEPQGRGYYSGVAALIGGDGQGGRTLDSAILIRTAEIESDGRLRIG 360 
            ****************************************************.******* 
 
PAO1_1      VGSTIVRHSDPLGEAAESRAKASGLIAALKSQAPQRLGSHPHVVAALASRNAPIADFWLR 420 
PAO1_2      VGSTIVRHSDPLGEAAESRAKASGLIAALKSQAPQRLGSHPHVVAALASRNAPIADFWLR 420 
PA14_1      VGSTIVRHSDPLGEAAESRAKASGLIAALKSQAPQRLGSHPHVVAALASRNAPIADFWLR 420 
PA14_2      VGSTIVRHSDPLGEAAESRAKASGLIAALKSQAPQRLGSHPHVVAALASRNAPIADFWLR 420 
            ************************************************************ 
 
PAO1_1      GASERQQLQADLSGREVLIVDAEDTFTSMIAKQLKSLGLTVTVRGFQEPYSFDGYDLVIM 480 
PAO1_2      GASERQQLQADLSGREVLIVDAEDTFTSMIAKQLKSLGLTVTVRGFQEPYSFDGYDLVIM 480 
PA14_1      GASERQQLQADLSGREVLIVDAEDTFTSMIAKQLKSLGLTVTVRGFQEPYSFDGYDLVIM 480 
PA14_2      GASERQQLQADLSGREVLIVDAEDTFTSMIAKQLKSLGLTVTVRGFQEPYSFDGYDLVIM 480 
            ************************************************************ 
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PAO1_1      GPGPGNPTEIGQPKIGHLHLAIRSLLSERRPFLAVCLSHQVLSLCLGLDLQRRQEPNQGV 540 
PAO1_2      GPGPGNPTEIGQPKIGHLHLAIRSLLSERRPFLAVCLSHQVLSLCLGLDLQRRQEPNQGV 540 
PA14_1      GPGPGNPTEIGQPKIGHLHLAIRSLLSERRPFLAVCLSHQVLSLCLGLDLQRRQEPNQGV 540 
PA14_2      GPGPGNPTEIGQPKIGHLHLAIRSLLSERRPFLAVCLSHQVLSLCLGLDLQRRQEPNQGV 540 
            ************************************************************ 
 
PAO1_1      QKQIDLFGAAERVGFYNTFAARALQDRIEIPEVGPIEISRDRETGEVHALRGPRFASMQF 600 
PAO1_2      QKQIDLFGAAERVGFYNTFAARALQDRIEIPEVGPIEISRDRETGEVHALRGPRFASMQF 600 
PA14_1      QKQIDLFGAAERVGFYNTFAARALQDRIEIPEVGPIEISRDRETGEVHALRGPRFASMQF 600 
PA14_2      QKQIDLFGAAERVGFYNTFAARALQDRIEIPEVGPIEISRDRETGEVHALRGPRFASMQF 600 
            ************************************************************ 
 
PAO1_1      HPESVLTREGPRIIADLLRHALVERRP 627 
PAO1_2      HPESVLTREGPRIIADLLRHALVERRP 627 
PA14_1      HPESVLTREGPRIIADLLRHALVERRP 627 
PA14_2      HPESVLTREGPRIIADLLRHALVERRP 627 
            *************************** 
 
Alignment for PhzF: 
 
CLUSTAL O(1.2.4) multiple sequence alignment 
 
PAO1_1      MHRYVVIDAFASEPLQGNPVAVFFDCDDLSGERMQRMAREMNLSESTFVLRPQQDGDARI 60 
PAO1_2      MHRYVVIDAFASEPLQGNPVAVFFDCDDLSGERMQRMAREMNLSESTFVLRPQQDGDARI 60 
PA14_1      MHRYVVIDAFASEPLQGNPVAVFFDCDDLSGERMQRMAREMNLSESTFVLRPQQDGDARI 60 
PA14_2      MHRYVVIDAFASEPLQGNPVAVFFDCDDLSGERMQRMAREMNLSESTFVLRPQQDGDARI 60 
            ************************************************************ 
 
PAO1_1      RIFTPVNELPFAGHPLLGTAIALGAETDKDRLFLETRMGTVPFALERQDGKVVACSMQQP 120 
PAO1_2      RIFTPVNELPFAGHPLLGTAIALGAETDKDRLFLETRMGTVPFALERQDGKVVACSMQQP 120 
PA14_1      RIFTPVNELPFAGHPLLGTAIALGAETDKDRLFLETRMGTVPFALERQDGKVVACSMQQP 120 
PA14_2      RIFTPVNELPFAGHPLLGTAIALGAETDKDRLFLETRMGTVPFALERQDGKVVACSMQQP 120 
            ************************************************************ 
 
PAO1_1      IPTWEHFSRPAELLAALGLKGSTFPIEVYRNGPRHVFVGLESVAALSALHPDHRALCDFP 180 
PAO1_2      IPTWEHFSRPAELLAALGLKGSTFPIEVYRNGPRHVFVGLESVAALSALHPDHRALCDFP 180 
PA14_1      IPTWEHFSRPAELLAALGLKGSTFPIEVYRNGPRHVFVGLESVAALSALHPDHRALCDFP 180 
PA14_2      IPTWEHFSRPAELLAALGLKGSTFPIEVYRNGPRHVFVGLESVAALSALHPDHRALCDFP 180 
            ************************************************************ 
 
PAO1_1      DLAVNCFAGAGRHWRSRMFSPAYGVVEDAATGSAAGPLAIHLARHRQIPYGQQIEILQGV 240 
PAO1_2      DLAVNCFAGAGRHWRSRMFSPAYGVVEDAATGSAAGPLAIHLARHRQIPYGQQIEILQGV 240 
PA14_1      DLAVNCFAGAGRHWRSRMFSPAYGVVEDAATGSAAGPLAIHLARHRQIPYGQQIEILQGV 240 
PA14_2      DLAVNCFAGAGRHWRSRMFSPAYGVVEDAATGSAAGPLAIHLARHRQIPYGQQIEILQGV 240 
            ************************************************************ 
 
PAO1_1      EIGRPSRMYARAEGAGERVSAVEVSGNGAAFAEGRAYL 278 
PAO1_2      EIGRPSRMYARAEGAGERVSAVEVSGNGAAFAEGRAYL 278 
PA14_1      EIGRPSRMYARAEGAGERVSAVEVSGNGAAFAEGRAYL 278 
PA14_2      EIGRPSRMYARAEGAGERVSAVEVSGNGAAFAEGRAYL 278 
            ************************************** 
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Alignment for PhzG: 
 
CLUSTAL O(1.2.4) multiple sequence alignment 
 
PAO1_1      -MGVNANISESLTGTIEAPFPEFEAPPANPMEVLRNWLERARRYGVREPRALALATVDGQ 59 
PAO1_2      MMGVNANISESLTGTIEAPFPEFEAPPANPMEVLRNWLERARRYGVREPRALALATVDGQ 60 
PA14_1      MMGVNANISESLTGTIEAPFPEFEAPPANPMEVLRNWLERARRYGVREPRALALATVDGQ 60 
PA14_2      MMGVNANISESLTGTIEAPFPEFEAPPANPMEVLRNWLERARRYGVREPRALALATVDGQ 60 
             *********************************************************** 
 
PAO1_1      GRPSTRIVVIAELGERGVVFATHADSQKGRELAQNPWASGVLYWRESSQQIILNGRAERL 119 
PAO1_2      GRPSTRIVVIAELGERGVVFATHADSQKGRELAQNPWASGVLYWRESSQQIILNGRAERL 120 
PA14_1      GRPSTRIVVIAELGERGVVFATHADSQKGRELAQNPWASGVLYWRESSQQIILNGRAERL 120 
PA14_2      GRPSTRIVVIAELGERGVVFATHADSQKGRELAQNPWASGVLYWRESSQQIILNGRAERL 120 
            ************************************************************ 
 
PAO1_1      PDERADAQWLSRPYQTHPMSIASRQSETLADIHALRAEARRLAETDGPLPRPPGYCLFEL 179 
PAO1_2      PDERADAQWLSRPYQTHPMSIASRQSETLADIHALRAEARRLAETDGPLPRPPGYCLFEL 180 
PA14_1      PDERADAQWLSRPYQTHPMSIASRQSETLADIHALRAEARRLAETDGPLPRPPGYCLFEL 180 
PA14_2      PDERADAQWLSRPYQTHPMSIASRQSETLADIHALRAAARRLAETDGPLPRPPGYCLFEL 180 
            ************************************* ********************** 
PAO1_1      CLESVEFWGNGTERLHERLRYDRDEGGWKHRYLQP 214 
PAO1_2      CLESVEFWGNGTERLHERLRYDRDEGGWKHRYLQP 215 
PA14_1      CLESVEFWGNGTERLHERLRYDRDEGGWKHRYLQP 215 
PA14_2      CLESVEFWGNGTERLHERLRYDRDEGGWKHRYLQP 215 
            *********************************** 
 
Data S2 - Other regulatory elements: 
 
Other intergenic regions presenting RBS have been detected but with no differences among 
them.   
 
This region is located between phzE and phzF. 
 
PAO1_1      gccaggagagccc  
PAO1_2      gccaggagagccc 
PA14_1      gccaggagagccc 
PA14_2      gccaggagagccc 
            ************* 
This region is located between phzF and phzG. 
 
PAO1_1      acgggcagaacggaggaacgcc 
PAO1_2      acgggcagaacggaggaacgcc 
PA14_1      acgggcagaacggaggaacgcc 
PA14_2      acgggcagaacggaggaacgcc 
            ********************** 
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Table S1: Codon Adaptation Index data (Caiazza et al.) for all genes belonging to the four 
clusters of interest. This index is a measurement to predict the level of expression of a gene 
taking into account the codon usage, being 1 the best expressed and 0 the worst expressed. 
 
 
Figure S2: Structural alignment PhzS. PA14-PhzS is used as the reference for the alignment (blue). RMSD for 
PAO1-PhzS (purple): 0.178 Å. 
 
Figure S3: Phylogenetic tree and genomic plot of the phenazine production clusters. Links between homology 
genes are represented with red shading where the intensity of the colour is decreasing with the length of 
the gene. Unique amino acid changes are marked with an x in the best phenazine-producing cluster 
(PA14.2). 
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C Structural analysis of phenazine synthesis proteins: 
 
Figure S4: Structural alignment PhzA. PA14-PhzA2 is used as the reference for the alignment (blue). RMSD for 
PA14-PhzA1 (pink): 0.177 Å. RMSD for PAO1-PhzA1 (light purple): 0.141 Å. RMSD for PAO1-PhzA2 
(green): 0.249 Å. Unique amino acid changes regarding PA14-PhzA2 (p.L97F) are marked in purple. 
 
Figure S5: Structural alignment PhzB. PA14-PhzB2 is used as the reference for the alignment (green). RMSD for 
PA14-PhzB1 (pink): 0.277 Å. RMSD for PAO1-PhzB1 (light purple): 0.348 Å. PAO1-PhzB2 is identical to 
PA14-PhzB2. 
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Figure S6: Structural alignment PhzC. PA14-PhzC2 is used as the reference for the alignment (blue). RMSD for 
PA14-PhzC1 (pink): 0.185 Å. RMSD for PAO1-PhzC1 (green): 0.209 Å. PAO1-PhzC2 is identical to PAO1-
PhzC1. 
 
Figure S7: Structural alignment PhzD. PA14-PhzD2 is used as the reference for the alignment (blue). RMSD for 
PA14-PhzD1 (green): 0.059 Å. PAO1-PhzD1 and PAO1-PhzD2 are identical to PA14-PhzD1. Unique amino 
acid changes regarding PA14-PhzD2 (p.K28E) are marked in purple. 
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Figure S8: Structural alignment PhzG. PA14-PhzG2 is used as the reference for the alignment (blue). RMSD for 
PA14-PhzG1 (green): 0.231 Å. RMSD for PAO1-PhzG1 (light purple): 0.159 Å. PAO1-PhzG2 is identical to 
PA14-PhzG1. Unique amino acid changes regarding PA14-PhzG2 (p.A158E) are marked in purple. 
 
A.2 Supplementary information Chapter 3.2 
A Constructed Plasmids expressing phenazine and rhamnolipid genes used in Chapter 3.2  
 
 
Figure S9: Vectors expressing mono-rhamnolipid and phenazine genes used in chapter 3.2; (a) pJNN.rhlAB, 
expressing rhlA and rhlB from P. aeruginosa PAO1; (b) pJNN.rhlAB.phzMS, expressing rhlA, rhlB, phzM, 
and phzS from P. aeruginosa PAO1; The schemes represent all of the important elements, including the 
phenazine genes (phzA-G), the Kanamycin resistance cassette (kmR) for Pseudomonas, the ampicillin 
resistance cassette for E.coli (bla), the terminator (Tn-1), the origin of replication (ori RO1600 for 
Pseudomonas and ori CoIE1 for E.coli), and the salycilate-induced promoter (pnagAa/nagR). 
  
A11 
 
B BES experiments 
 
Figure S10: Bioreactor performance of P. putida rhl strain without electrode. AA at a flow rate of 30 ml/minute for 
48 hours, then continued with passive headspace aeration. The reactors data are means from biological 
triplicates. 
 
Figure S11: BES performance of P. putida rhl at an applied potential of 0.2 V vs. RE. BES set up under active 
aeration, AA, at a flow rate of 30 ml/minute for 48 hours, then continued with passive headspace 
aeration. The BES data are means from biological triplicates. 
 
 
Figure S12: Bioreactor performance of P. putida rhl-pca strain without electrode. AA at a flow rate of 
30 ml/minute for 48 hours, then continued with passive headspace aeration. The reactors data are 
means from biological triplicates. 
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Figure S13: BES performance of P. putida rhl-pca (plasmid sustainability test) at an applied potential of 0.2 V vs. 
RE. BES set up under active aeration plus, AA+, at a flow rate of 50 ml/minute continuously until the 
end of the experiment. The BES data was from single reactor. 
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Figure S14: Second BES performance of P. putida rhl-pca at an applied potential of 0.2 V vs. RE. (a-c) BES set up 
under passive aeration (replication experiment). The BES data are means from biological triplicate. The 
data showed in the same range to first experiment for all of parameters. 
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